# EDGAR Filing Document

**Accession Number:** 0000074046
**File Stem:** 0001628280-26-041539
**Filing Date:** 2026-6
**Character Count:** 150184
**Document Hash:** fb35467a632a6c7d3b237545948dd4fa
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001628280-26-041539.hdr.sgml**: 20260608

**ACCESSION NUMBER**: 0001628280-26-041539

**CONFORMED SUBMISSION TYPE**: 10-Q

**PUBLIC DOCUMENT COUNT**: 68

**CONFORMED PERIOD OF REPORT**: 20260430

**FILED AS OF DATE**: 20260608

**DATE AS OF CHANGE**: 20260608

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Oil-Dri Corp of America
- **CENTRAL INDEX KEY:** 0000074046
- **STANDARD INDUSTRIAL CLASSIFICATION:** MISCELLANEOUS MANUFACTURING INDUSTRIES [3990]
- **ORGANIZATION NAME:** 04 Manufacturing
- **EIN:** 362048898
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 0731

**FILING VALUES:**
- **FORM TYPE:** 10-Q
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-12622
- **FILM NUMBER:** 261072691

**BUSINESS ADDRESS:**
- **STREET 1:** 410 NORTH MICHIGAN AVENUE
- **STREET 2:** SUITE 400
- **CITY:** CHICAGO
- **STATE:** IL
- **ZIP:** 60611
- **BUSINESS PHONE:** 3123211515

**MAIL ADDRESS:**
- **STREET 1:** 410 NORTH MICHIGAN AVENUE
- **STREET 2:** SUITE 400
- **CITY:** CHICAGO
- **STATE:** IL
- **ZIP:** 60611

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** OIL-DRI Corp OF AMERICA
- **DATE OF NAME CHANGE:** 20170417

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** OIL DRI CORP OF AMERICA
- **DATE OF NAME CHANGE:** 20170307

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** OIL-DRI CORP OF AMERICA
- **DATE OF NAME CHANGE:** 20170306

?xml version='1.0' encoding='ASCII'? odc-20260430

    

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

(Mark One)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

☒ Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934For the Quarterly Period Ended April 30, 2026or

☐ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934For the transition period from _____________ to ______________

Commission File Number: <u>001-12622</u> 

<u>OIL-DRI CORPORATION OF AMERICA</u> 

(Exact name of the registrant as specified in its charter)

---

| | |
|:---|:---|
| <u>Delaware</u>  | <u>36-2048898</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;(State or other jurisdiction of incorporation or organization) | (I.R.S. Employer Identification No.) |
| &nbsp;&nbsp;&nbsp;&nbsp;(State or other jurisdiction of incorporation or organization) |  |
| <u>410 North Michigan Avenue, Suite 400</u> |  |
| <u>Chicago, Illinois</u>  | <u>60611-4213</u>  |
| (Address of principal executive offices) | &nbsp;&nbsp;&nbsp;&nbsp;(Zip Code) |
| The registrant's telephone number, including area code: <u>(312) 321-1515</u>  | The registrant's telephone number, including area code: <u>(312) 321-1515</u>  |

---

Securities registered pursuant to Section 12(b) of the Act:

---

| | | |
|:---|:---|:---|
| **Title of each class** | **Trading Symbol(s)** | **Name of each exchange on which registered** |
| Common Stock, par value $0.10 per share | ODC | New York Stock Exchange |

---

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports) and (2) has been subject to such filing requirements for at least the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act.

---

| | |
|:---|:---|
| Large Accelerated Filer □ | Non-accelerated Filer □ |
| Accelerated Filer ⌧ | Smaller Reporting Company □ |
| | Emerging Growth Company □ |

---

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

As of May 31, 2026, 10,254,395 shares of the registrant's Common Stock and 4,233,940 shares of the registrant's Class B Stock were outstanding.

------

**TABLE OF CONTENTS**

---

| | | |
|:---|:---|:---|
| | **PART I – FINANCIAL INFORMATION** | |
| | | **<u>Page</u>** |
| **Item 1:** | [Financial Statements](#i94a1acf6699a46b8bf42835dde595853_13) | <u>[3](#i94a1acf6699a46b8bf42835dde595853_13)</u> |
| **Item 2:** | [Management's Discussion and Analysis of Financial Condition and Results](#i94a1acf6699a46b8bf42835dde595853_85)<u>[o](#i94a1acf6699a46b8bf42835dde595853_85)</u>[f Operations](#i94a1acf6699a46b8bf42835dde595853_85) | <u>[26](#i94a1acf6699a46b8bf42835dde595853_85)</u> |
| **Item 3:** | [Quantitative and Qualitative Disclosures About Market Risk](#i94a1acf6699a46b8bf42835dde595853_109)  | <u>[33](#i94a1acf6699a46b8bf42835dde595853_109)</u> |
| **Item 4:** | [Controls and Procedures](#i94a1acf6699a46b8bf42835dde595853_115) | <u>[33](#i94a1acf6699a46b8bf42835dde595853_115)</u> |
|  | **PART II – OTHER INFORMATION** |  |
| **Item 1A:** | [Risk Factors](#i94a1acf6699a46b8bf42835dde595853_121) | <u>[34](#i94a1acf6699a46b8bf42835dde595853_121)</u> |
| **Item 2:** | [Unregistered Sales of Equity Securities and Use of Proceeds](#i94a1acf6699a46b8bf42835dde595853_124)  | <u>[35](#i94a1acf6699a46b8bf42835dde595853_124)</u> |
| **Item 4:** | [Mine Safety Disclosures](#i94a1acf6699a46b8bf42835dde595853_127)  | <u>[35](#i94a1acf6699a46b8bf42835dde595853_127)</u> |
| **Item 6:** | [Exhibits](#i94a1acf6699a46b8bf42835dde595853_133) | <u>[36](#i94a1acf6699a46b8bf42835dde595853_133)</u> |
|  | [Signatures](#i94a1acf6699a46b8bf42835dde595853_136) | <u>[37](#i94a1acf6699a46b8bf42835dde595853_136)</u> |

---

**FORWARD-LOOKING STATEMENTS**

Certain statements in this report, including, but not limited to, under the heading "Management's Discussion and Analysis of Financial Condition and Results of Operations," and elsewhere in this report and in other documents that we file with the U.S. Securities and Exchange Commission ("SEC"), may constitute forward-looking statements within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Our forward-looking statements include, but are not limited to, statements regarding our or our management team's expectations, hopes, beliefs, intentions or strategies regarding the future. In addition, any statements that refer to projections, forecasts or other characterizations of future events or circumstances, including any underlying assumptions, are forward-looking statements. These forward-looking statements are based on management's current expectations, estimates, forecasts, assumptions and projections about future events, our future performance, the future of our business, our plans and strategies, projections, anticipated trends, the economy and other future developments and their potential effects on us. In addition, we, or others on our behalf, may make forward-looking statements in press releases or written statements, or in our communications and discussions with investors and analysts in the normal course of business through meetings, webcasts, phone calls and conference calls. Forward-looking statements can be identified by words such as "expect," "endeavor," "outlook," "forecast," "would," "could," "should," "project," "intend," "plan," "continue," "believe," "seek," "estimate," "anticipate," "may," "assume," "potential," "foresee," "predict," "possible," "commit," "design," "strive," and variations of such words and similar references to future periods.

Such statements are subject to certain risks, uncertainties and assumptions that could cause actual results to differ materially from those anticipated, intended, expected, believed, estimated, projected, planned or otherwise expressed in any forward-looking statements, including, but not limited to, those described herein, in our Annual Report on Form 10-K for the fiscal year ended July 31, 2025, and from time to time in our other filings with the SEC.

Investors are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. Except to the extent required by law, we do not have any intention or obligation to update publicly any forward-looking statements after the distribution of this report, whether as a result of new information, future events, changes in assumptions or otherwise.

**TRADEMARK NOTICE**

"Oil-Dri" is a registered trademark of Oil-Dri Corporation of America.

------

**PART I - FINANCIAL INFORMATION**

**ITEM 1. Financial Statements**

**OIL-DRI CORPORATION OF AMERICA**

**Condensed Consolidated Balance Sheet**

(in thousands, except for share and per share amounts, unaudited)

---

| | | |
|:---|:---|:---|
| **ASSETS** | **April 30,<br>2026** | **July 31,<br>2025** |
| **<u>Current Assets</u>** | | |
| Cash and cash equivalents | $**62941** | $50458 |
| Accounts receivable, net of allowances of $1,065 and $1,493 at April 30, 2026 and July 31, 2025, respectively | **75772** | 69370 |
| Inventories, net | **52420** | 51594 |
| Prepaid expenses and other assets | **5212** | 5961 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Total Current Assets** | **196345** | 177383 |
| **<u>Other Assets</u>** |  |  |
| Property, plant and equipment, net | **150799** | 149704 |
| Goodwill | **16017** | 16017 |
| Trademarks, trade names and patents, net of accumulated amortization of $724 and $693 at April 30, 2026 and July 31, 2025, respectively | **6575** | 6603 |
| Customer list, net of accumulated amortization of $10,124 and $9,278 at April 30, 2026 and July 31, 2025, respectively | **18061** | 18907 |
| Deferred income taxes | **1182** | 1291 |
| Operating lease right-of-use assets | **13440** | 14219 |
| Other | **6371** | 7553 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Total Other Assets** | **212445** | 214294 |
| **Total Assets** | $**408790** | $391677 |

---

The accompanying notes are an integral part of the Condensed Consolidated Financial Statements.

------

**OIL-DRI CORPORATION OF AMERICA**

**Condensed Consolidated Balance Sheet (continued)** 

(in thousands, except for share and per share amounts, unaudited)

---

| | | |
|:---|:---|:---|
| **LIABILITIES & STOCKHOLDERS' EQUITY** | **April 30,<br>2026** | **July 31,<br>2025** |
| **<u>Current Liabilities</u>** | | |
| Current maturities of notes payable | $**1000** | $1000 |
| Accounts payable | **13848** | 16808 |
| Dividends payable | **2750** | 2444 |
| Operating lease liabilities | **3936** | 4071 |
| Accrued expenses | **38386** | 44864 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Total Current Liabilities** | **59920** | 69187 |
| **<u>Noncurrent Liabilities</u>** |  |  |
| Long-term debt, net of unamortized debt issuance costs of $153 and $183 at April 30, 2026 and July 31, 2025, respectively | **38847** | 38817 |
| Deferred compensation | **6419** | 5777 |
| Long-term operating lease liabilities | **10546** | 11296 |
| Other | **7832** | 7540 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Total Noncurrent Liabilities** | **63644** | 63430 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Total Liabilities** | **123564** | 132617 |
| **Commitments and contingencies (See note 7)** |  |  |
| **<u>Stockholders' Equity</u>** |  |  |
| Common Stock, par value $.10 per share, issued 15,349,661 shares at April 30, 2026<br>&nbsp;&nbsp;&nbsp;&nbsp;and 15,276,261 shares at July 31, 2025  | **1535** | 1528 |
| Class B Stock, par value $.10 per share, issued 4,650,484 shares at April 30, 2026<br>&nbsp;&nbsp;&nbsp;&nbsp;and 4,650,484 shares at July 31, 2025 | **465** | 465 |
| Additional paid-in capital | **70344** | 66138 |
| Retained earnings | **312119** | 277500 |
| Accumulated other comprehensive income | **976** | 969 |
| Less Treasury Stock, at cost (5,095,266 Common and 416,544 Class B shares at <br>April 30, 2026 and 4,902,881 Common and 380,628 Class B shares at July 31, 2025) | **(100213)** | (87540) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Total Stockholders' Equity** | **285226** | 259060 |
| **Total Liabilities & Stockholders' Equity** | $**408790** | $391677 |

---

The accompanying notes are an integral part of the Condensed Consolidated Financial Statements.

------

**OIL-DRI CORPORATION OF AMERICA**

**Condensed Consolidated Statements of Operations**

(in thousands, except for share and per share amounts, unaudited)

---

| | | |
|:---|:---|:---|
| | **For the Nine Months Ended April 30,** | **For the Nine Months Ended April 30,** |
| | **2026** | **2025** |
| **Net Sales** | $**364552** | $360360 |
| **Cost of Goods Sold** | **(263027)** | (252110) |
| **Gross Profit** | **101525** | 108250 |
| **Selling, General and Administrative Expenses** | **(51785)** | (55674) |
| **Income from Operations** | **49740** | 52576 |
| **Other Income (Expense)** |  |  |
| &nbsp;&nbsp;&nbsp;Interest expense | **(1648)** | (1888) |
| &nbsp;&nbsp;&nbsp;Interest income | **1087** | 358 |
| &nbsp;&nbsp;&nbsp;Other, net | **2220** | (336) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Total Other Income (Expense), Net** | **1659** | (1866) |
| **Income Before Income Taxes** | **51399** | 50710 |
| **Income Tax Expense** | **(8848)** | (9769) |
| **Net Income** | **42551** | 40941 |
| **Earnings Per Share** |  |  |
| &nbsp;&nbsp;&nbsp;Basic Common | $**3.15** | $3.03 |
| &nbsp;&nbsp;&nbsp;Basic Class B | $**2.37** | $2.28 |
| &nbsp;&nbsp;&nbsp;Diluted Common | $**2.93** | $2.81 |
| &nbsp;&nbsp;&nbsp;&nbsp;Diluted Class B | $**2.37** | $2.28 |
| **Average Shares Outstanding** |  |  |
| &nbsp;&nbsp;&nbsp;Basic Common | **9884** | 9882 |
| &nbsp;&nbsp;&nbsp;Basic Class B | **4035** | 3991 |
| &nbsp;&nbsp;&nbsp;Diluted Common | **13919** | 13873 |
| &nbsp;&nbsp;&nbsp;&nbsp;Diluted Class B | **4035** | 3991 |
| **Dividends Declared Per Share** |  |  |
| &nbsp;&nbsp;&nbsp;Common Stock | $**0.590** | $0.465 |
| &nbsp;&nbsp;&nbsp;Class B Stock | $**0.441** | $0.350 |

---

The accompanying notes are an integral part of the Condensed Consolidated Financial Statements.

------

**OIL-DRI CORPORATION OF AMERICA**

**Condensed Consolidated Statements of Comprehensive Income**

(in thousands, unaudited)

---

| | | |
|:---|:---|:---|
| | **For the Nine Months Ended April 30,** | **For the Nine Months Ended April 30,** |
| | **2026** | **2025** |
| **Net Income Attributable to Oil-Dri** | $**42551** | $40941 |
| Other Comprehensive Income (Loss): |  |  |
| &nbsp;&nbsp;&nbsp;Postretirement expenses (net of tax) | **(64)** | (71) |
| &nbsp;&nbsp;&nbsp;Cumulative translation adjustment | **71** | 53 |
| **Other Comprehensive Income (Loss)** | **7** | (18) |
| **Total Comprehensive Income** | $**42558** | $40923 |

---

The accompanying notes are an integral part of the Condensed Consolidated Financial Statements.

------

**OIL-DRI CORPORATION OF AMERICA**

**Condensed Consolidated Statements of Operations**

(in thousands, except for share amounts, unaudited)

---

| | | |
|:---|:---|:---|
| | **For the Three Months Ended April 30,** | **For the Three Months Ended April 30,** |
| | **2026** | **2025** |
| **Net Sales** | $**126329** | $115501 |
| **Cost of Goods Sold** | **(92601)** | (82479) |
| **Gross Profit** | **33728** | 33022 |
| **Selling, General and Administrative Expenses** | **(16635)** | (19118) |
| **Income from Operations** | **17093** | 13904 |
| **Other Income (Expense)** |  |  |
| &nbsp;&nbsp;&nbsp;Interest expense | **(537)** | (548) |
| &nbsp;&nbsp;&nbsp;Interest income | **386** | 122 |
| &nbsp;&nbsp;&nbsp;Other, net | **969** | 770 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Total Other Income, Net** | **818** | 344 |
| **Income Before Income Taxes** | **17911** | 14248 |
| **Income Tax Expense** | **(3385)** | (2604) |
| **Net Income** | **14526** | 11644 |
| **Earnings Per Share** |  |  |
| &nbsp;&nbsp;&nbsp;**Basic Common** | $**1.08** | $0.86 |
| &nbsp;&nbsp;**Basic Class B** | $**0.81** | $0.65 |
| &nbsp;&nbsp;&nbsp;**Diluted Common** | $**1.00** | $0.80 |
| &nbsp;&nbsp;&nbsp;&nbsp;**Diluted Class B** | $**0.81** | $0.65 |
| **Average Shares Outstanding** |  |  |
| &nbsp;&nbsp;&nbsp;**Basic Common** | **9848** | 9907 |
| &nbsp;&nbsp;**Basic Class B** | **4048** | 4002 |
| &nbsp;&nbsp;&nbsp;**Diluted Common** | **13896** | 13909 |
| &nbsp;&nbsp;&nbsp;&nbsp;**Diluted Class B** | **4048** | 4002 |
| **Dividends Declared Per Share** |  |  |
| &nbsp;&nbsp;&nbsp;**Basic Common** | $**0.2050** | $0.1550 |
| &nbsp;&nbsp;**Basic Class B** | $**0.1530** | $0.1165 |

---

The accompanying notes are an integral part of the Condensed Consolidated Financial Statements.

------

**OIL-DRI CORPORATION OF AMERICA**

**Condensed Consolidated Statements of Comprehensive Income**

(in thousands, unaudited)

---

| | | |
|:---|:---|:---|
| | **For the Three Months Ended April 30,** | **For the Three Months Ended April 30,** |
| | **2026** | **2025** |
| **Net Income Attributable to Oil-Dri** | $**14526** | $11644 |
| Other Comprehensive Income (Loss): |  |  |
| &nbsp;&nbsp;Postretirement expenses (net of tax) | **(21)** | (24) |
| &nbsp;&nbsp;&nbsp;Cumulative translation adjustment | **(78)** | 214 |
| **Other Comprehensive (Loss) Income** | **(99)** | 190 |
| **Total Comprehensive Income** | $**14427** | $11834 |

---

The accompanying notes are an integral part of the Condensed Consolidated Financial Statements.

------

**OIL-DRI CORPORATION OF AMERICA**

**Condensed Consolidated Statements of Stockholders' Equity**

(in thousands, except for share amounts, unaudited)

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **For the Three Months Ended April 30** | **For the Three Months Ended April 30** | **For the Three Months Ended April 30** | **For the Three Months Ended April 30** | **For the Three Months Ended April 30** | **For the Three Months Ended April 30** | **For the Three Months Ended April 30** | **For the Three Months Ended April 30** |
| | **Number of Shares** | **Number of Shares** | | | | | | |
| | **Common & Class B Stock** | **Treasury<br>Stock** | **Common<br>& Class B<br>Stock** | **Additional<br>Paid-In<br>Capital** | **Retained<br>Earnings** | **Treasury<br>Stock** | **Accumulated<br>Other<br>Comprehensive<br>Income** | **Total<br>Stockholders'<br>Equity** |
| **Balance, January 31, 2025** | **19866445** | **(5275972)** | $**1987** | $**63195** | $**257349** | $**(87232)** | $**561** | $**235860** |
| Net Income |  |  |  |  | 11644 |  |  | 11644 |
| Other Comprehensive Income |  |  |  |  |  |  | 190 | 190 |
| Dividends Declared |  |  |  |  | (2104) |  |  | (2104) |
| Purchases of Treasury Stock |  | (1545) |  |  |  | (69) |  | (69) |
| Net issuance of stock under long-term incentive plans | 53300 | (400) | 5 | 3 |  | (8) |  |  |
| Amortization of Restricted Stock |  | **—** |  | 1338 |  |  |  | 1338 |
| **Balance, April 30, 2025** | **19919745** | **(5277917)** | $**1992** | $**64536** | $**266889** | $**(87309)** | $**751** | $**246859** |
| **Balance, January 31, 2026** | **19989245** | **(5506829)** | $**1999** | $**68980** | $**300343** | $**(99947)** | $**1075** | $**272450** |
| Net Income |  |  |  |  | 14526 |  |  | 14526 |
| Other Comprehensive Loss |  |  |  |  |  |  | (99) | (99) |
| Dividends Declared |  |  |  |  | (2750) |  |  | (2750) |
| Purchases of Treasury Stock |  | (2481) |  |  |  | (173) |  | (173) |
| Net issuance of stock under long-term incentive plans | 10900 | (2500) | 1 | 92 |  | (93) |  |  |
| Amortization of Restricted Stock |  |  |  | 1272 |  |  |  | 1272 |
| **Balance, April 30, 2026** | **20000145** | **(5511810)** | $**2000** | $**70344** | $**312119** | $**(100213)** | $**976** | $**285226** |

---

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **For the Nine Months Ended April 30** | **For the Nine Months Ended April 30** | **For the Nine Months Ended April 30** | **For the Nine Months Ended April 30** | **For the Nine Months Ended April 30** | **For the Nine Months Ended April 30** | **For the Nine Months Ended April 30** | **For the Nine Months Ended April 30** |
| | **Number of Shares** | **Number of Shares** | | | | | | |
| | **Common & Class B Stock** | **Treasury Stock** |<br>**Common & Class B Stock** |<br>**Additional Paid-In Capital** |<br>**Retained Earnings** |<br>**Treasury Stock** |<br>**Accumulated Other Comprehensive Income** |<br>**Total Stockholders' Equity** |
| **Balance, July 31, 2024** | **19825170** | **(5230529)** | $**1982** | $**60031** | $**232247** | $**(84441)** | $**769** | $**210588** |
| Net Income |  |  |  |  | 40941 |  |  | 40941 |
| Other Comprehensive Loss |  |  |  |  |  |  | (18) | (18) |
| Dividends Declared |  |  |  |  | (6299) |  |  | (6299) |
| Purchases of Treasury Stock |  | (34966) |  |  |  | (2233) |  | (2233) |
| Net issuance of stock under long-term incentive plans | 94575 | (12422) | 10 | 625 |  | (635) |  |  |
| Amortization of Restricted Stock |  |  |  | 3880 |  |  |  | 3880 |
| **Balance, April 30, 2025** | **19919745** | **(5277917)** | $**1992** | $**64536** | $**266889** | $**(87309)** | $**751** | $**246859** |
| **Balance, July 31, 2025** | **19926745** | **(5283509)** | $**1993** | $**66138** | $**277500** | $**(87540)** | $**969** | $**259060** |
| Net Income |  |  |  |  | 42551 |  |  | 42551 |
| Other Comprehensive Income |  |  |  |  |  |  | 7 | 7 |
| Dividends Declared |  |  |  |  | (7932) |  |  | (7932) |
| Purchases of Treasury Stock |  | (224601) |  |  |  | (12537) |  | (12537) |
| Net issuance of stock under long-term incentive plans | 73400 | (3700) | 7 | 129 |  | (136) |  |  |
| Amortization of Restricted Stock |  |  |  | 4077 |  |  |  | 4077 |
| **Balance, April 30, 2026** | **20000145** | **(5511810)** | $**2000** | $**70344** | $**312119** | $**(100213)** | $**976** | $**285226** |

---

The accompanying notes are an integral part of the Condensed Consolidated Financial Statements.

------

**OIL-DRI CORPORATION OF AMERICA**

**Condensed Consolidated Statements of Cash Flows** 

(in thousands, unaudited)

---

| | | |
|:---|:---|:---|
| | **For the Nine Months Ended April 30,** | **For the Nine Months Ended April 30,** |
| **<u>CASH FLOWS FROM OPERATING ACTIVITIES</u>** | **2026** | **2025** |
| **Net Income** | $**42551** | $40941 |
| Adjustments to reconcile net income to net cash provided by operating activities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Depreciation and amortization | **17186** | 16391 |
| &nbsp;&nbsp;&nbsp;&nbsp;Non-cash stock-based compensation | **4077** | 3880 |
| &nbsp;&nbsp;&nbsp;&nbsp;Provision for bad debts and cash discounts | **(169)** | 436 |
| &nbsp;&nbsp;&nbsp;&nbsp;Loss on impairment of patent applications | **—** | 48 |
| &nbsp;&nbsp;&nbsp;&nbsp;Accretion of asset retirement obligation | **190** | 143 |
| &nbsp;&nbsp;&nbsp;&nbsp;Loss on the disposals of property, plant and equipment | **413** | 29 |
| &nbsp;&nbsp;&nbsp;&nbsp;(Increase) decrease in assets: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accounts receivable | **(6203)** | (3816) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Inventories | **(766)** | (2547) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Prepaid expenses | **463** | 1234 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Deferred income taxes | **73** | (116) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other assets | **4091** | 3012 |
| &nbsp;&nbsp;&nbsp;&nbsp;Increase (decrease) in liabilities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accounts payable | **(641)** | 495 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accrued expenses | **(5529)** | (2268) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Deferred compensation | **642** | 548 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other liabilities | **(3170)** | (3422) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Total Adjustments** | **10657** | 14047 |
| &nbsp;&nbsp;&nbsp;&nbsp;**Net Cash Provided by Operating Activities** | **53208** | 54988 |
| **<u>CASH FLOWS FROM INVESTING ACTIVITIES</u>** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Capital expenditures | **(20918)** | (24483) |
| &nbsp;&nbsp;&nbsp;&nbsp;Proceeds from sale of property, plant and equipment | **—** | 89 |
| &nbsp;&nbsp;&nbsp;&nbsp;Acquisition of a business | **—** | (115) |
| &nbsp;&nbsp;&nbsp;&nbsp;Dispositions of short-term investments | **312** |  |
| &nbsp;&nbsp;&nbsp;&nbsp;**Net Cash Used in Investing Activities** | **(20606)** | (24509) |
| **<u>CASH FLOWS FROM FINANCING ACTIVITIES</u>** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Payments on revolving credit facility | **—** | (10000) |
| &nbsp;&nbsp;&nbsp;&nbsp;Dividends paid | **(7626)** | (6290) |
| &nbsp;&nbsp;&nbsp;&nbsp;Purchases of treasury stock | **(12537)** | (2233) |
| &nbsp;&nbsp;&nbsp;&nbsp;**Net Cash Used in Financing Activities** | **(20163)** | (18523) |
| Effect of exchange rate changes on cash and cash equivalents | **44** | 38 |
| **Net Increase in Cash and Cash Equivalents** | **12483** | 11994 |
| **Cash, Cash Equivalents and Restricted Cash, Beginning of Period** | **50458** | 24481 |
| **Cash, Cash Equivalents and Restricted Cash, End of Period** | $**62941** | $36475 |

---

The accompanying notes are an integral part of the Condensed Consolidated Financial Statements.

------

**OIL-DRI CORPORATION OF AMERICA**

**Condensed Consolidated Statements of Cash Flows - Continued**

(in thousands, unaudited)

---

| | | |
|:---|:---|:---|
| | **For the Nine Months Ended April 30,** | **For the Nine Months Ended April 30,** |
| | **2026** | **2025** |
| **Supplemental disclosures:** |  |  |
| Restricted Cash included in prepaid expenses and other assets: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Beginning balance | $**—** | $1000 |
| &nbsp;&nbsp;&nbsp;&nbsp;Converted to unrestricted cash | $**—** | $(885) |
| &nbsp;&nbsp;&nbsp;&nbsp;Final settlement of acquisition of Ultra Pet | $**—** | $(115) |
| &nbsp;&nbsp;&nbsp;&nbsp;Ending balance | $**—** | $— |
| Other cash flows: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Interest payments, net of amounts capitalized | $1152 | $1172 |
| &nbsp;&nbsp;&nbsp;&nbsp;Income tax payments, net of refunds | $7635 | $9588 |
| Non-cash investing and financing activities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Change in capital expenditures in accounts payable | $(2323) | $(2253) |
| &nbsp;&nbsp;&nbsp;&nbsp;Change in capital expenditures in accrued expenses | $(1014) | $(4620) |
| &nbsp;&nbsp;&nbsp;&nbsp;Cash dividends declared and accrued | $2750 | $2105 |

---

The accompanying notes are an integral part of the Condensed Consolidated Financial Statements.

------

**OIL-DRI CORPORATION OF AMERICA**

**Notes To Condensed Consolidated Financial Statements**

(Unaudited)

**1. BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES**

**Basis of Presentation**

The accompanying unaudited Condensed Consolidated Financial Statements have been prepared in accordance with accounting principles generally accepted in the United States of America ("U.S. GAAP") for interim financial information and in compliance with instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. The financial statements and the related notes are condensed and should be read in conjunction with the Consolidated Financial Statements and related notes included in our Annual Report on Form 10-K for the fiscal year ended July 31, 2025.

The unaudited Condensed Consolidated Financial Statements include the accounts of Oil-Dri Corporation of America and its subsidiaries. All significant intercompany transactions are eliminated. Except as otherwise indicated herein or as the context otherwise requires, references to "Oil-Dri," the "Company," "we," "us" or "our" refer to Oil-Dri Corporation of America and its subsidiaries.

The unaudited Condensed Consolidated Financial Statements reflect all adjustments, consisting of normal recurring accruals which are, in the opinion of management, necessary for a fair presentation of the statements contained herein. Operating results for the three and nine months ended April 30, 2026, are not necessarily an indication of the results that may be expected for the fiscal year ending July 31, 2026.

**Management Use of Estimates**

The preparation of the unaudited Condensed Consolidated Financial Statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, and disclosure of contingent assets and liabilities as of the date of the unaudited Condensed Consolidated Financial Statements and the reported amounts of revenues and expenses during the reporting period, as well as the related disclosures. Estimates and assumptions about future events cannot be made with certainty. All of our estimates and assumptions are revised periodically. Actual results could differ from these estimates.

**Summary of Significant Accounting Policies**

Our significant accounting policies, which are summarized in detail in our Annual Report on Form 10-K for the fiscal year ended July 31, 2025, have not materially changed. The following is a description of certain of our significant accounting policies:

**Trade Receivables.** We recognize trade receivables when control of finished products is transferred to our customers. We record an allowance for credit losses based on our expectations and a periodic review of our accounts receivable, including a review of the overall aging of accounts, consideration of customer credit risk, and analysis of facts and circumstances about specific accounts. A customer account is determined to be uncollectible when it is probable that a loss will be incurred after we have completed our internal collection procedures, including termination of shipments, direct customer contact and formal demand of payment. We retain outside collection agencies to facilitate our collection efforts. Past due status is determined based on contractual terms and customer payment history. We also include an allowance for expected cash discounts to be taken by our customers. Accounts receivable was $75.8 million, $69.4 million, and $62.2 million as of April 30, 2026, July 31, 2025, and July 31, 2024, respectively.

**Property, Plant and Equipment.** Property, plant and equipment includes depreciable assets such as building, machinery, equipment, furniture, vehicles, and capitalized spare parts. These assets are depreciated using the straight-line method over their estimated useful lives. Major improvements and betterments are capitalized, while maintenance and repairs that do not extend the useful life or increase functionality of the applicable assets are expensed as incurred. Interest expense may also be capitalized for assets that require a period of time to prepare them for their intended use.

These assets are carried at cost on the unaudited Condensed Consolidated Balance Sheet and are reviewed for possible impairment on an annual basis or when circumstances indicate that an asset may become impaired. We take into consideration idle and underutilized equipment and review business plans for possible impairment. When impairment is indicated, an

------

impairment charge is recorded for the difference between the carrying value of the asset and its fair market value.

The composition of property, plant and equipment is as follows (in thousands):

---

| | | |
|:---|:---|:---|
| | **April 30,<br>2026** | **July 31,<br>2025** |
| Gross property, plant and equipment | $**366934** | $356079 |
| Accumulated depreciation and amortization | **(216135)** | (206375) |
| Total Property, Plant and Equipment, Net | $**150799** | $149704 |

---

**Land, Mining Property and Mineral Rights.** We surface mine sorbent minerals on property that we either own or lease as part of our overall operations. A significant part of our overall mining cost is incurred during the process of removing the overburden (non-usable material) from the mine site, thus exposing the sorbent material used in a majority of our production processes. These stripping costs are treated as a variable inventory production cost and are included in cost of goods sold in the period they are incurred. We defer and amortize the pre-production overburden removal costs during the development phase associated with opening a new mine.

Additionally, it is our policy to capitalize the purchase cost of land and mineral rights, including associated legal, survey and real estate fees. The costs of obtaining mineral rights, including legal fees and drilling expenses, are also capitalized. Pre-production development costs on new mines and any prepaid royalties that may be offset against future royalties due upon extraction of the minerals are also capitalized. All exploration related costs are expensed as incurred.

**Reclamation.** We perform ongoing reclamation activities during the normal course of our overburden removal. As overburden is removed from a mine site, it is hauled to previously mined sites and is used to refill older sites. This process allows us to continuously reclaim older mine sites and dispose of overburden simultaneously, therefore minimizing the costs associated with the reclamation process.

On an annual basis we evaluate our potential reclamation liability in accordance with ASC 410, *Asset Retirement and Environmental Obligations.* The reclamation assets are depreciated over the estimated useful lives of the respective mines. The reclamation liabilities are increased based on a yearly accretion charge over the estimated useful lives of the respective mines.

**Leases.** ASC 842, *Leases*, provides that a contract is, or contains, a lease if it conveys the right to control the use of an identified asset and, accordingly, a lease liability and a related right-of-use ("ROU") asset is recognized at the commencement date on our unaudited Condensed Consolidated Balance Sheet. As provided in ASC 842, we have elected not to apply these measurements and recognition requirements to short-term leases (i.e., leases with a term of 12 months or less). Short-term leases will not be recorded as ROU assets or lease liabilities on our unaudited Condensed Consolidated Balance Sheet, and the related lease payments will be recognized in net earnings on a straight-line basis over the lease term. For leases other than short-term leases, the lease liability is equal to the present value of unpaid lease payments over the remaining lease term. The lease term may reflect options to extend or terminate the lease when it is reasonably certain that such options will be exercised. To determine the present value of the lease liability, we use an incremental borrowing rate, which is defined as the rate of interest we would have to pay to borrow (on a collateralized basis over a similar term) an amount equal to the lease payments in similar economic environments. The ROU asset is based on the corresponding lease liability adjusted for certain costs such as initial direct costs, prepaid lease payments and lease incentives received. Both operating and finance lease ROU assets are reviewed for impairment, consistent with other long-lived assets, whenever events or changes in circumstances indicate that the carrying amount may not be recoverable. After a ROU asset is impaired, any remaining balance of the ROU asset is amortized on a straight-line basis over the shorter of the remaining lease term or the estimated useful life. After the lease commencement date, we evaluate lease modifications, if any, that could result in a change in the accounting for leases.

Certain of our leases provide for variable lease payments that vary due to changes in facts and circumstances occurring after the commencement date, other than the passage of time. Variable lease payments that are dependent on an index or rate (e.g., the Consumer Price Index) are included in the initial measurement of the lease liability and the ROU asset. Variable lease payments that are not known at the commencement date and are determinable based on the performance or use of the underlying asset, are expensed as incurred. Our variable lease payments primarily include common area maintenance charges based on the percentage of the total square footage leased and the usage of assets, such as photocopiers.

------

Some of our contracts may contain lease components as well as non-lease components, such as an agreement to purchase services. As allowed under ASC 842, we have elected not to separate the lease components from non-lease components for all asset classes, and we will not allocate the contract consideration to these components. This policy was applied to all existing leases upon adoption of ASC 842 and will be applied to new leases on an ongoing basis.

**Revenue Recognition.** We recognize revenue when performance obligations under the terms of the contracts with customers are satisfied. Our performance obligation generally consists of the promise to sell finished products to wholesalers, distributors, retailers or consumers and our obligations have an original duration of one year or less. Control of the finished products are generally transferred upon shipment to, or receipt at, customers' locations, as determined by the specific terms of the orders. We have one customer who requested that the title and risk of loss transfer when production is completed. For that customer, we produce and physically segregate finished goods in our warehouses. We have completed our performance obligation when control is transferred, and we recognize revenue accordingly. Taxes collected from customers and remitted to governmental authorities are excluded from net sales. Sales returns are not material nor are warranties or any related obligations.

We have an unconditional right to consideration under the payment terms specified in the contracts upon completion of the performance obligation. We may require certain customers to provide payment in advance of product shipment. We recorded a liability for these advance payments of $0.6 million as of April 30, 2026 and $0.3 million as of July 31, 2025. This liability is reported in Other within Accrued Expenses on the unaudited Condensed Consolidated Balance Sheet. There was $0.3 million revenue recognized during the nine months ended April 30, 2026, that was included in the liability for advance payments at the beginning of the period.

We routinely commit to one-time or ongoing trade promotion programs directly with consumers, such as coupon programs, and also with customers, such as volume discounts, cooperative marketing and other arrangements. We estimate and accrue the expected costs of these programs. These costs are considered variable consideration under ASC 606, *Revenue from Contracts with Customers*, and are netted against sales when revenue is recorded. The accruals are based on our best estimate of the amounts necessary to settle future and existing obligations on products sold as of the balance sheet date. To estimate these accruals, we rely on our historical experience of trade spending patterns and that of the industry, current trends and forecasted data.

**Selling, General and Administrative Expenses.** Selling, general and administrative expenses ("SG&A") include salaries, wages and benefits associated with staff outside the manufacturing and distribution functions, all marketing related costs, any miscellaneous trade spending expenses not required to be included in net sales, research and development costs, depreciation and amortization related to assets outside the manufacturing and distribution process, and all other non-manufacturing and non-distribution expenses.

**Other Current and Noncurrent Liabilities.** Other liabilities include the accruals for general expenses not yet paid, cash collected not yet vouchered, legal reserves, postretirement health benefit obligations, and reclamation liability accrual. Current liabilities are due to be paid within the next 12 months. Other noncurrent liabilities on the unaudited Condensed Consolidated Balance Sheet include $6.1 million and $5.9 million for the reclamation liability as of April 30, 2026, and July 31, 2025, respectively, and $1.7 million and $1.6 million for the postretirement health benefit as of April 30, 2026 and July 31, 2025, respectively.

**New Accounting Pronouncements and Regulations.** 

***Recently Adopted Accounting Standards***

In November 2023, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") No. 2023-07, "Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures" ("ASU 2023-07"). These amendments primarily require enhanced disclosures about significant segment expenses regularly provided to the chief operating decision maker and included within each reported measure of segment profit or loss. In addition, ASU No. 2023-07 also requires all annual disclosures currently required by Topic 280 to be included in interim periods. These amendments are to be applied retrospectively for all periods presented in the financial statements and are effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024, with early adoption permitted. Refer to Note 10 - Operating Segments of this Form 10-Q for the enhanced disclosures added as a result of the adoption of ASU 2023-07.

------

***Recently Issued Accounting Standards Not Yet Adopted***

In December 2023, the FASB issued ASU No. 2023-09, "Income Taxes (Topic 740): Improvements to Income Tax Disclosures." These amendments primarily require enhanced disclosures and disaggregation of income tax information by jurisdiction in the annual income tax reconciliation and quantitative disclosures regarding income taxes paid. These amendments are to be applied prospectively, with the option to apply the standard retrospectively, for annual periods beginning after December 15, 2024. Early adoption is permitted. We plan to adopt this amendment as of July 31, 2026. We do not expect the amendment to have a material impact on the Company's consolidated financial statement disclosures.

In November 2024, the FASB issued ASU No. 2024-03, "Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses" ("ASU 2024-03"). The pronouncement expands the disclosure requirements for expenses, specifically by providing more detailed information about the types of expenses in commonly presented expense captions. ASU 2024-03 is effective for fiscal years beginning after December 15, 2026, and interim periods within fiscal years beginning after December 15, 2027. We are currently evaluating the impact that ASU 2024-03 will have on the Company's consolidated financial statement disclosures.

In July 2025, the FASB issued ASU 2025-05, "Measurement of Credit Losses for Accounts Receivable and Contract Assets" ("ASU 2025-05"), which provides a practical expedient that assumes current conditions as of the balance sheet date remain unchanged when developing forecasts for estimating expected credit losses. Under ASU 2025-05, an entity is required to disclose that it has elected to use the practical expedient and the election should be applied prospectively. ASU 2025-05 is effective for fiscal years, and interim periods within those years, beginning after December 15, 2025, with early adoption permitted. We do not expect the amendment to have a material impact on the Company's consolidated financial statement disclosures, however we will continue to assess through the adoption period.

In September 2025, the FASB issued ASU 2025-06, "Intangibles—Goodwill and Other—Internal-Use Software (Subtopic 350-40): Targeted Improvements to the Accounting for Internal-Use Software" ("ASU 2025-06"), which provides clarification and improvements to the accounting for internal-use software costs under ASC 350-40, Intangibles – Goodwill and Other – Internal-Use Software. The guidance includes amendments related to capitalization of implementation costs, subsequent measurement, and related presentation and disclosure requirements. ASU 2025-06 is effective for fiscal years beginning after December 15, 2027, including interim periods within those fiscal years. We are currently evaluating the impact that ASU 2025-06 will have on the Company's consolidated financial statement disclosures.

In December 2025, the FASB issued ASU 2025-10, "Government Grants (Topic 832): Accounting for Government Grants Received by Business Entities" ("ASU 2025-10"). This amendment establishes authoritative guidance on the recognition, measurement and presentation of government grants received by business entities. ASU 2025-10 is effective for fiscal years beginning after December 15, 2028, including interim periods within those years, with early adoption permitted. Given the nature of our existing government-related arrangements, we do not expect the amendment to have a material impact on the Company's consolidated financial statement disclosures, however we will continue to assess through the adoption period.

In December 2025, the FASB issued ASU 2025-11, "Interim Reporting (Topic 270): Narrow-Scope Improvements" ("ASU 2025-11"). These amendments are intended to improve the navigability of interim reporting guidance, clarify when ASC 270 applies, and provide a comprehensive list of required interim disclosures including a requirement for entities to disclose events that occur after the end of the most recent annual reporting period that have a material impact on the entity. ASU 2025-11 is effective for interim periods within fiscal years beginning after December 15, 2027, with early adoption permitted. We are currently evaluating the impact that ASU 2025-11 will have on the Company's consolidated financial statement disclosures.

In December 2025, the FASB issued ASU 2025-12, "Codification Improvements" ("ASU 2025-12") which includes amendments for technical corrections, clarifications and revisions to existing codification intended to improve consistency of application, remove ambiguity and enhance overall usability. These improvements do not introduce new accounting requirements and are not expected to result in significant changes to accounting practices. ASU 2025-12 is effective for annual periods beginning after December 15, 2026, including interim periods within those fiscal years. We are currently evaluating the impact that ASU 2025-12 will have on the Company's consolidated financial statement disclosures.

------

**2. EARNINGS PER SHARE**

We utilize the two-class method to report our earnings per share ("EPS"). The two-class method is an earnings allocation formula that determines EPS for each class of common stock according to dividends declared and participation rights in undistributed earnings. Common Stock is entitled to cash dividends equal to at least 133.33% on a per share basis of the cash dividend paid on Class B Stock. In computing EPS, the Company has allocated dividends declared to shares of Common Stock and Class B Stock based on amounts declared for each class of stock and 33.33% more of the undistributed earnings have been allocated to shares of Common Stock than to shares of Class B Stock on a per share basis. Common Stock is entitled to one vote per share and Class B Stock is entitled to ten votes per share. Common Stock have no conversion rights. Class B Stock is convertible by the holders thereof on a share-by-share basis into Common Stock at any time and is subject to mandatory conversion under certain circumstances. Basic EPS is computed by dividing net earnings, reduced for any distributed and undistributed earnings allocated to unvested restricted shares, by the weighted-average number of shares outstanding during the period for each class of common stock. Diluted EPS for Common Stock is derived utilizing the most dilutive result of the if-converted, treasury stock and two-class methods. In our case, the if-converted method is more dilutive than the two-class method and because our unvested restricted stock participates in dividends and is therefore anti-dilutive the treasury stock method does not apply. For Class B Stock, diluted EPS is derived utilizing the two-class method since, as with our Common Stock, our unvested restricted stock participates in dividends and is therefore anti-dilutive, making the treasury stock method inapplicable. The reverse treasury stock method is also inapplicable to both classes as we have no obligation to repurchase our Common Stock or Class B Stock. In both the if-converted and two-class methods, diluted EPS is computed by dividing net earnings by the weighted-average number of shares and potential shares outstanding during the period, taking into consideration different potential shares outstanding based on the method used. Dilution for Common Stock takes into consideration the effect of both unvested restricted shares and convertible shares of Class B Stock, unless such shares are anti-dilutive, in which case they are not considered. Dilution for Class B Stock takes into consideration the effect of unvested restricted shares, unless such shares are anti-dilutive, in which case they are not considered.

Below is a reconciliation of the calculation of basic and diluted EPS.

------

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **For the Nine Months Ended April 30, 2026** | **For the Nine Months Ended April 30, 2026** | **For the Nine Months Ended April 30, 2026** | **For the Nine Months Ended April 30, 2025** | **For the Nine Months Ended April 30, 2025** | **For the Nine Months Ended April 30, 2025** |
| | (in thousands, except for per share data) | (in thousands, except for per share data) | (in thousands, except for per share data) | (in thousands, except for per share data) | (in thousands, except for per share data) | (in thousands, except for per share data) |
| | **Total** | **Common** | **Class B** | **Total** | **Common** | **Class B** |
| Net income | $42551 | $32501 | $10050 | $40941 | $31201 | $9740 |
| Distributed and undistributed earnings on restricted shares | $(1820) | $(1334) | $(486) | $(1940) | $(1285) | $(655) |
| Income available to stockholders | $40731 | $31167 | $9564 | $39001 | $29916 | $9085 |
| Net Income (Numerator) |  | $31167 | $9564 |  | $29916 | $9085 |
| Weighted Average Shares Outstanding (Denominator) |  | 9884 | 4035 |  | 9882 | 3991 |
| **Basic EPS** |  | $**3.15** | $**2.37** |  | $**3.03** | $**2.28** |
| Effect of dilution - Net Income <sup>(1)</sup> |  | $9564 | $— |  | $9085 | $— |
| Net income assuming dilution (Numerator) |  | $40731 | $9564 |  | $39001 | $9085 |
| Effect of dilution - Shares <sup>(1)</sup> |  | 4035 |  |  | 3991 |  |
| Shares assuming dilution (Denominator) |  | 13919 | 4035 |  | 13873 | 3991 |
| **Diluted EPS** |  | $**2.93** | $**2.37** |  | $**2.81** | $**2.28** |
| <sup>(1)</sup> The impact of 281,219 unvested shares of Common Stock and 135,090 unvested shares of Class B Stock were anti-dilutive therefore not included in the calculation of diluted EPS for the nine months ended April 30, 2026. The impact of 259,469 unvested shares of Common Stock and 124,187 unvested shares of Class B Stock were anti-dilutive, and therefore not included in the calculation of diluted EPS for the nine months ended April 30, 2025.  | <sup>(1)</sup> The impact of 281,219 unvested shares of Common Stock and 135,090 unvested shares of Class B Stock were anti-dilutive therefore not included in the calculation of diluted EPS for the nine months ended April 30, 2026. The impact of 259,469 unvested shares of Common Stock and 124,187 unvested shares of Class B Stock were anti-dilutive, and therefore not included in the calculation of diluted EPS for the nine months ended April 30, 2025.  | <sup>(1)</sup> The impact of 281,219 unvested shares of Common Stock and 135,090 unvested shares of Class B Stock were anti-dilutive therefore not included in the calculation of diluted EPS for the nine months ended April 30, 2026. The impact of 259,469 unvested shares of Common Stock and 124,187 unvested shares of Class B Stock were anti-dilutive, and therefore not included in the calculation of diluted EPS for the nine months ended April 30, 2025.  | <sup>(1)</sup> The impact of 281,219 unvested shares of Common Stock and 135,090 unvested shares of Class B Stock were anti-dilutive therefore not included in the calculation of diluted EPS for the nine months ended April 30, 2026. The impact of 259,469 unvested shares of Common Stock and 124,187 unvested shares of Class B Stock were anti-dilutive, and therefore not included in the calculation of diluted EPS for the nine months ended April 30, 2025.  | <sup>(1)</sup> The impact of 281,219 unvested shares of Common Stock and 135,090 unvested shares of Class B Stock were anti-dilutive therefore not included in the calculation of diluted EPS for the nine months ended April 30, 2026. The impact of 259,469 unvested shares of Common Stock and 124,187 unvested shares of Class B Stock were anti-dilutive, and therefore not included in the calculation of diluted EPS for the nine months ended April 30, 2025.  | <sup>(1)</sup> The impact of 281,219 unvested shares of Common Stock and 135,090 unvested shares of Class B Stock were anti-dilutive therefore not included in the calculation of diluted EPS for the nine months ended April 30, 2026. The impact of 259,469 unvested shares of Common Stock and 124,187 unvested shares of Class B Stock were anti-dilutive, and therefore not included in the calculation of diluted EPS for the nine months ended April 30, 2025.  | <sup>(1)</sup> The impact of 281,219 unvested shares of Common Stock and 135,090 unvested shares of Class B Stock were anti-dilutive therefore not included in the calculation of diluted EPS for the nine months ended April 30, 2026. The impact of 259,469 unvested shares of Common Stock and 124,187 unvested shares of Class B Stock were anti-dilutive, and therefore not included in the calculation of diluted EPS for the nine months ended April 30, 2025.  |
|  | **For the Three Months Ended April 30, 2026** | **For the Three Months Ended April 30, 2026** | **For the Three Months Ended April 30, 2026** | **For the Three Months Ended April 30, 2025** | **For the Three Months Ended April 30, 2025** | **For the Three Months Ended April 30, 2025** |
|  | (in thousands, except for per share data) | (in thousands, except for per share data) | (in thousands, except for per share data) | (in thousands, except for per share data) | (in thousands, except for per share data) | (in thousands, except for per share data) |
|  | **Total** | **Common** | **Class B** | **Total** | **Common** | **Class B** |
| Net income | $14526 | $11097 | $3429 | $11644 | $8884 | $2760 |
| Distributed and undistributed earnings on restricted shares | (623) | (472) | (151) | (540) | (367) | (173) |
| Income available to stockholders | $13903 | $10625 | $3278 | $11104 | $8517 | $2587 |
| Net Income (Numerator) |  | $10625 | $3278 |  | $8517 | $2587 |
| Weighted Average Shares Outstanding (Denominator) |  | 9848 | 4048 |  | 9907 | 4002 |
| **Basic EPS** |  | $**1.08** | $**0.81** |  | $**0.86** | $**0.65** |
| Effect of dilution - Net Income <sup>(1)</sup> |  | $3278 | $— |  | $2587 | $— |
| Net income assuming dilution (Numerator) |  | $13903 | $3278 |  | $11104 | $2587 |
| Effect of dilution - Shares <sup>(1)</sup> |  | 4048 |  |  | 4002 |  |
| Shares assuming dilution (Denominator) |  | 13896 | 4048 |  | 13909 | 4002 |
| **Diluted EPS** |  | $**1.00** | $**0.81** |  | $**0.80** | $**0.65** |
| <sup>(1)</sup> The impact of 267,018 unvested shares of Common Stock and 125,345 unvested shares of Class B Stock were anti-dilutive therefore not included in the calculation of diluted EPS for the three months ended April 30, 2026. The impact of 268,920 unvested shares of Common Stock and 132,528 unvested shares of Class B Stock were anti-dilutive, and therefore not included in the calculation of diluted EPS for the three months ended April 30, 2025.  | <sup>(1)</sup> The impact of 267,018 unvested shares of Common Stock and 125,345 unvested shares of Class B Stock were anti-dilutive therefore not included in the calculation of diluted EPS for the three months ended April 30, 2026. The impact of 268,920 unvested shares of Common Stock and 132,528 unvested shares of Class B Stock were anti-dilutive, and therefore not included in the calculation of diluted EPS for the three months ended April 30, 2025.  | <sup>(1)</sup> The impact of 267,018 unvested shares of Common Stock and 125,345 unvested shares of Class B Stock were anti-dilutive therefore not included in the calculation of diluted EPS for the three months ended April 30, 2026. The impact of 268,920 unvested shares of Common Stock and 132,528 unvested shares of Class B Stock were anti-dilutive, and therefore not included in the calculation of diluted EPS for the three months ended April 30, 2025.  | <sup>(1)</sup> The impact of 267,018 unvested shares of Common Stock and 125,345 unvested shares of Class B Stock were anti-dilutive therefore not included in the calculation of diluted EPS for the three months ended April 30, 2026. The impact of 268,920 unvested shares of Common Stock and 132,528 unvested shares of Class B Stock were anti-dilutive, and therefore not included in the calculation of diluted EPS for the three months ended April 30, 2025.  | <sup>(1)</sup> The impact of 267,018 unvested shares of Common Stock and 125,345 unvested shares of Class B Stock were anti-dilutive therefore not included in the calculation of diluted EPS for the three months ended April 30, 2026. The impact of 268,920 unvested shares of Common Stock and 132,528 unvested shares of Class B Stock were anti-dilutive, and therefore not included in the calculation of diluted EPS for the three months ended April 30, 2025.  | <sup>(1)</sup> The impact of 267,018 unvested shares of Common Stock and 125,345 unvested shares of Class B Stock were anti-dilutive therefore not included in the calculation of diluted EPS for the three months ended April 30, 2026. The impact of 268,920 unvested shares of Common Stock and 132,528 unvested shares of Class B Stock were anti-dilutive, and therefore not included in the calculation of diluted EPS for the three months ended April 30, 2025.  | <sup>(1)</sup> The impact of 267,018 unvested shares of Common Stock and 125,345 unvested shares of Class B Stock were anti-dilutive therefore not included in the calculation of diluted EPS for the three months ended April 30, 2026. The impact of 268,920 unvested shares of Common Stock and 132,528 unvested shares of Class B Stock were anti-dilutive, and therefore not included in the calculation of diluted EPS for the three months ended April 30, 2025.  |

---

**3. INVENTORIES**

The composition of inventories is as follows (in thousands):

---

| | | |
|:---|:---|:---|
| | **April 30,<br>2026** | **July 31,<br>2025** |
| Finished goods | $**29970** | $29401 |
| Packaging | **7985** | 8114 |
| Spare parts | **6679** | 6822 |
| Other | **7786** | 7257 |
| Total Inventories | $**52420** | $51594 |

---

Inventories are valued at the lower of cost (first-in, first-out) or net realizable value. Inventory costs include the cost of raw materials, packaging supplies, labor, and other overhead costs. The Company maintains reserves against inventory to reduce the carrying value to the expected net realizable value. These reserves are based upon a combination of factors including historical issues and market trends. Inventory reserves were $3.8 million as of April 30, 2026 and $3.7 million as of July 31, 2025.

------

**4. FAIR VALUE MEASUREMENTS**

Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The inputs used to measure fair value are prioritized into categories based on the lowest level of input that is significant to the fair value measurement. The categories in the fair value hierarchy are as follows:

Level 1: Quoted market prices in active markets for identical assets or liabilities.

Level 2: Observable market-based inputs for similar assets or liabilities or valuation models whose inputs are observable, directly or indirectly.

Level 3: Unobservable inputs.

Cash equivalents are classified as Level 1 of the fair value hierarchy because they are valued using quoted market prices in active markets. These cash instruments are primarily money market funds and are included in cash and cash equivalents on the unaudited Condensed Consolidated Balance Sheet. We had $46.2 million in cash equivalents as of April 30, 2026, and $35.3 million in cash equivalents as of July 31, 2025.

Balances of accounts receivable, short-term investments and accounts payable approximated their fair values as of April 30, 2026, and July 31, 2025, due to the short maturity and nature of those balances.

Debt is reported at outstanding face value, less unamortized debt issuance costs. The estimated fair value of debt, including current maturities, was $40.7 million and $40.3 million as of April 30, 2026, and July 31, 2025, respectively. The fair value was estimated using the exit price notion of fair value and is classified as Level 2. See Note 8 of the Notes to the unaudited Condensed Consolidated Financial Statements for further information about such debt.

**5. INTANGIBLE ASSETS AND GOODWILL**

Our intangible assets are mainly comprised of customer lists, patents, trademarks, trade names and goodwill.

We amortize customer lists on a straight-line basis over a useful life of 18 years and patents on a straight-line basis over periods ranging from 7 to 20 years. Estimated intangible amortization for fiscal year 2026 is $1.2 million. Estimated intangible amortization for each of the next five fiscal years is $1.2 million.

Trademarks and trade names acquired via acquisitions, with a carrying value of $5.6 million, were determined to have an indefinite life and are not amortized.

There have been no triggering events in fiscal years 2026 or 2025 that would indicate a new impairment analysis is needed.

**6. ACCRUED EXPENSES**

Accrued expenses are as follows (in thousands):

---

| | | |
|:---|:---|:---|
| | **April 30,<br>2026** | **July 31,<br>2025** |
| Salaries, Wages, Commissions and Employee Benefits | $**14933** | $20532 |
| Payables | **12962** | 13036 |
| Trade Promotions and Advertising | **2976** | 3105 |
| Freight | **2961** | 2700 |
| Taxes | **1687** | 2249 |
| Georgia Landfill Modification Reserve | **149** | 819 |
| Other | **2718** | 2423 |
|  | $**38386** | $**44864** |

---

------

**7. OTHER CONTINGENCIES**

We are party to various legal actions that arise from time to time that are ordinary in nature and incidental to the operation of our business, including ongoing litigation. While it is not possible at this time to determine with certainty the ultimate outcome of these or other lawsuits, we believe that none of the pending proceedings will have a material adverse effect on our business, financial condition, results of operations or cash flows.

In fiscal year 2023, we recorded a reserve of $2.5 million for anticipated modification costs that we expected to incur to address capacity issues at our sole landfill located in Ochlocknee, Georgia. Reserves are recorded when it is probable that a liability has been incurred, and the amount of the liability can be reasonably estimated. The amount of the reserve represented management's best estimate of the costs for the modification with respect to this matter, at the time. Work began on the modifications during fiscal year 2024. We increased the total estimated cost by $0.6 million and $0.7 million in fiscal years 2024 and 2025, respectively. In fiscal year 2026, we decreased the total estimated cost by $0.2 million resulting in a total $3.6 million expense related to this matter. The modification work is expected to be completed during fiscal year 2026 and, as inherent uncertainties exist in these estimates, we will monitor through the completion of the modification but do not expect that remaining costs in excess of amounts accrued would have a material impact on the Company's results of operations, financial condition and cash flows.

**8. DEBT**

We are party to an Amended and Restated Note Purchase and Private Shelf Agreement (as amended, the "Note Agreement") with PGIM, Inc. ("Prudential") and certain existing noteholders and purchasers affiliated with Prudential named therein. Pursuant to the Note Agreement, (i) on May 15, 2020, we issued $10 million in aggregate principal amount of our 3.95% Series B Senior Notes due May 15, 2030 (the "Series B Senior Notes"), of which $5 million aggregate principal amount remained outstanding as of April 30, 2026, (ii) on December 16, 2021, we issued an additional $25 million in aggregate principal amount of our 3.25% Series C Senior Notes due December 16, 2031 (the "Series C Senior Notes"), all of which remained outstanding as of April 30, 2026, and (iii) on April 30, 2024 we issued $10 million in aggregate principal amount of our 6.47% Series D Senior Notes due April 30, 2033 (the "Series D Senior Notes"), all of which remained outstanding as of April 30, 2026. The Note Agreement also provides us with the ability to request, from time to time until September 21, 2026, that Prudential affiliate(s) purchase, at Prudential's discretion and on an uncommitted basis, additional senior unsecured notes of Oil-Dri (the "Shelf Notes," and collectively with the Series B Senior Notes, Series C Senior Notes, and Series D Senior Notes, the "Notes") in an aggregate principal amount of up to $75 million minus the aggregate principal amount of Notes then outstanding and Shelf Notes that have been accepted for purchase. Interest payable on any Shelf Note agreed to be purchased under the Note Agreement will be at a rate determined by Prudential and will mature no more than fifteen years after the date of original issue of such Shelf Note.

We are party to the Credit Agreement, dated as of January 27, 2006 (as previously amended, the "Credit Agreement"), among us, BMO Harris Bank N.A ("BMO Bank"), and certain of our domestic subsidiaries. The Credit Agreement provides for a $75 million unsecured revolving credit facility, including a maximum of $20 million for letters of credit.

The Credit Agreement contains restrictive covenants that, among other things and under various conditions, limit our ability to incur additional indebtedness or to dispose of assets. These restrictive covenants include certain financial covenants such as a covenant to maintain a maximum debt to earnings ratio and to maintain a certain fixed charge coverage ratio. On September 30, 2024, the Company entered into the Eighth Amendment to Credit Agreement (the "Eighth Amendment"). The Eighth Amendment amends the Credit Agreement to, among other things: (i) increase the amount the Company may borrow from BMO Bank from time to time pursuant to its revolving line of credit from up to $45 million to up to $75 million; (ii) increase the aggregate maximum amount of letters of credit from up to $10 million to up to $20 million; (iii) add an accordion provision to allow the Company to increase the revolving line of credit by up to an additional $50 million, subject to the terms and conditions set forth in the Eighth Amendment; (iv) extend the termination date to September 30, 2029; and (v) increase certain restrictive covenant thresholds, including but not limited to, an increase to the permitted acquisitions threshold in the restricted covenants from a cumulative total of $45 million to $100 million.

As of April 30, 2026, and July 31, 2025, we were in compliance with the restrictive covenants under the Credit Agreement. There were no new borrowings during the third quarter of fiscal year 2026. As of April 30, 2026, we do not have any outstanding borrowings under the Credit Agreement. We had $3.0 million of letters of credit outstanding under the Credit Agreement as of both April 30, 2026, and July 31, 2025.

------

The Credit Agreement states that we may select a variable interest rate based on either the Bank of Montreal ("BMO") prime rate or an adjusted Secured Overnight Financing ("SOFR")-based rate, plus a margin that varies depending on our debt to earnings ratio, or a fixed rate as agreed between us and BMO. As of April 30, 2026, the variable rates would have been 6.75% for the BMO prime-based rate or 5.06% for the adjusted SOFR-based rate.

**9. LEASES**

We have operating leases primarily for real estate properties, including corporate headquarters, customer service and sales offices, manufacturing and packaging facilities, warehouses, and research and development facilities, as well as for rail tracks, railcars and office equipment. Certain of our leases for a shared warehouse and office facility, rail track and railcars have options to extend which we are reasonably certain we will exercise and, accordingly, have been considered in the lease term used to recognize our ROU assets and lease liabilities. To determine the present value of the lease liability, we use an incremental borrowing rate, which is defined as the rate of interest that the Company would have to pay to borrow (on a collateralized basis over a similar term) an amount equal to the lease payments in similar economic environments. Further information about our accounting policy for leases is included in Note 1 of the Notes to the unaudited Condensed Consolidated Financial Statements.

We have no material finance leases, and variable costs for operating leases are immaterial for the nine months ended April 30, 2026. Operating lease costs are included in Cost of Goods Sold or SG&A expenses in the unaudited Condensed Consolidated Statements of Operations based on the nature of the lease. The following table summarizes total lease costs for our operating leases (in thousands):

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **For the Three Months Ended April 30,** | **For the Three Months Ended April 30,** | **For the Nine Months Ended April 30,** | **For the Nine Months Ended April 30,** |
| | **For the Three Months Ended April 30,** | **For the Three Months Ended April 30,** | **For the Nine Months Ended April 30,** | **For the Nine Months Ended April 30,** |
| | **2026** | **2025** | **2026** | **2025** |
| Operating lease cost | $**1249** | $1337 | $**3709** | $4076 |
| Short-term operating lease cost | $**446** | $318 | $**1240** | $1025 |

---

Supplemental cash flow information related to leases was as follows (in thousands):

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **For the Three Months Ended April 30,** | **For the Three Months Ended April 30,** | **For the Nine Months Ended April 30,** | **For the Nine Months Ended April 30,** |
| | **For the Three Months Ended April 30,** | **For the Three Months Ended April 30,** | **For the Nine Months Ended April 30,** | **For the Nine Months Ended April 30,** |
| | **2026** | **2025** | **2026** | **2025** |
| Cash paid for amounts included in the measurement of operating lease liabilities: | $**1089** | $1137 | $**3214** | $3423 |
| Right-of-use assets obtained in exchange for new operating lease liabilities | $**52** | $— | $**2433** | $— |

---

Operating lease ROU assets and operating lease liabilities are separately presented on the unaudited Condensed Consolidated Balance Sheet, excluding leases with an initial term of twelve months or less. Other supplemental balance sheet information related to leases was as follows:

---

| | | |
|:---|:---|:---|
| | **April 30, 2026** | **July 31, 2025** |
| Weighted-average remaining lease term - operating leases | **4.6 years** | 4.8 years |
| Weighted-average discount rate - operating leases | **5.18%** | 5.12% |

---

------

Lease liability maturities as of April 30, 2026 are as follows (in thousands):

---

| | |
|:---|:---|
| Fiscal year 2026 (remaining three months) | $**1210** |
| Fiscal year 2027 | **4331** |
| Fiscal year 2028 | **3506** |
| Fiscal year 2029 | **2915** |
| Fiscal year 2030 | **1661** |
| Thereafter | **2544** |
| Total | **16167** |
| Less: imputed interest | **(1685)** |
| Net lease obligation | $**14482** |

---

**10. OPERATING SEGMENTS**

We have two reportable operating segments: (1) Retail and Wholesale Products Group and (2) Business to Business Products Group. The Retail and Wholesale Products Group is comprised of our Cat Litter and Industrial and Sports Products and the Business to Business Products Group is comprised of our Agricultural and Horticultural, Fluids Purification, and Animal Health & Nutrition Products. These operating segments are managed separately, and each segment's major customers have different characteristics. The Retail and Wholesale Products Group customers include mass merchandisers, the farm and fleet channel, drugstore chains, pet specialty retail outlets, dollar stores, retail grocery stores, distributors of industrial cleanup and automotive products, environmental service companies, sports field product users and marketers of consumer products. The Business to Business Products Group customers include processors and refiners of edible oils, renewable diesel, petroleum-based oils and biodiesel fuel; manufacturers of animal feed and agricultural chemicals; and distributors of animal health and nutrition products. Our operating segments are also our reportable segments. The accounting policies of the segments are the same as those described in Note 1 of the Notes to the Consolidated Financial Statements included in our Annual Report on Form 10-K for the fiscal year ended July 31, 2025.

Net sales for our principal products by segment are as follows (in thousands):

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Business to Business Products Group** | **Business to Business Products Group** | **Retail and Wholesale Products Group** | **Retail and Wholesale Products Group** |
| | **For the Nine Months Ended April 30,** | **For the Nine Months Ended April 30,** | **For the Nine Months Ended April 30,** | **For the Nine Months Ended April 30,** |
| **Product** | **2026** | **2025** | **2026** | **2025** |
| Cat Litter | $**—** | $— | $**198895** | $190656 |
| Industrial and Sports | **—** |  | **35553** | 35195 |
| Agricultural and Horticultural | **36615** | 32396 | **—** |  |
| Fluids Purification | **77180** | 82384 | **—** |  |
| Animal Health & Nutrition | **16309** | 19729 | **—** |  |
| Net Sales | $**130104** | $134509 | $**234448** | $225851 |
|  | **Business to Business Products Group** | **Business to Business Products Group** | **Retail and Wholesale Products Group** | **Retail and Wholesale Products Group** |
|  | **For the Three Months Ended April 30,** | **For the Three Months Ended April 30,** | **For the Three Months Ended April 30,** | **For the Three Months Ended April 30,** |
| **Product** | **2026** | **2025** | **2026** | **2025** |
| Cat Litter | $**—** | $— | $**69219** | $59743 |
| Industrial and Sports | **—** |  | **13269** | 13080 |
| Agricultural and Horticultural | **12442** | 11639 | **—** |  |
| Fluids Purification | **25040** | 25269 | **—** |  |
| Animal Health & Nutrition | **6359** | 5770 | **—** |  |
| Net Sales | $**43841** | $42678 | $**82488** | $72823 |

---

------

Our chief operating decision maker ("CODM") is our President and CEO. The CODM regularly reviews net sales, gross profit, and operating income by segment to assess profitability and assist in the allocation of resources. Net sales and operating income for each segment are provided below, along with the significant segment expense categories that are regularly provided and used by the CODM when assessing segment profitability and the allocation of resources. The significant amounts within the segment operating expenses include cost of goods sold, compensation and benefits, and advertising. Other operating expenses in the table below is comprised of all other SG&A expenses which include but are not limited to travel, research & development, technical service support, and amortization of intangibles. Our CODM reviews the performance of each segment regularly by analyzing financial results in conjunction with our internal financial forecasts.

The corporate expenses line in the table below represents certain unallocated expenses, including primarily salaries, wages and benefits, purchased services, rent, utilities and depreciation and amortization associated with corporate functions such as information systems, finance, legal, human resources and customer service.

---

| | | | |
|:---|:---|:---|:---|
| | **For the Nine Months Ended April 30, 2026** | **For the Nine Months Ended April 30, 2026** | **For the Nine Months Ended April 30, 2026** |
| *(in thousands)* | **Business to Business Products Group** | **Retail and Wholesale Products Group** | **Total** |
| **Net Sales** | $130104 | $234448 | $364552 |
| Cost of Goods Sold | (79334) | (183693) | (263027) |
| **Gross Profit** | **50770** | **50755** | **101525** |
| Compensation & Consultant | (7350) | (6364) | (13714) |
| Advertising | (736) | (4263) | (4999) |
| Other Operating Expenses | (4292) | (5658) | (9950) |
| **Operating Income** | **38392** | **34470** | **72862** |
| Corporate Expenses |  |  | (23122) |
| **Income from Operations** |  |  | **49740** |
| Total Other Income, Net  |  |  | 1659 |
| **Income Before Income Taxes** |  |  | **51399** |
| Income Tax Expense |  |  | (8848) |
| **Net Income** |  |  | $**42551** |
|  | **For the Nine Months Ended April 30, 2025** | **For the Nine Months Ended April 30, 2025** | **For the Nine Months Ended April 30, 2025** |
| *(in thousands)* | **Business to Business Products Group** | **Retail and Wholesale Products Group** | **Total** |
| **Net Sales** | $134509 | $225851 | $360360 |
| Cost of Goods Sold | (77672) | (174438) | (252110) |
| **Gross Profit** | **56837** | **51413** | **108250** |
| Compensation & Consultant | (6615) | (6358) | (12973) |
| Advertising | (886) | (4602) | (5488) |
| Other Operating Expenses | (4522) | (6039) | (10561) |
| **Operating Income** | **44814** | **34414** | **79228** |
| Corporate Expenses |  |  | (26652) |
| **Income from Operations** |  |  | **52576** |
| Total Other Expense, Net |  |  | (1866) |
| **Income Before Income Taxes** |  |  | **50710** |
| Income Tax Expense |  |  | (9769) |
| **Net Income** |  |  | $**40941** |

---

------

---

| | | | |
|:---|:---|:---|:---|
| | **For the Three Months Ended April 30, 2026** | **For the Three Months Ended April 30, 2026** | **For the Three Months Ended April 30, 2026** |
| *(in thousands)* | **Business to Business Products Group** | **Retail and Wholesale Products Group** | **Total** |
| **Net Sales** | $43841 | $82488 | $126329 |
| Cost of Goods Sold | (26694) | (65907) | (92601) |
| **Gross Profit** | **17147** | **16581** | **33728** |
| Compensation & Consultant | (2521) | (2087) | (4608) |
| Advertising | (169) | (1554) | (1723) |
| Other Operating Expenses | (1498) | (1641) | (3139) |
| **Operating Income** | **12959** | **11299** | **24258** |
| Corporate Expenses |  |  | (7165) |
| **Income from Operations** |  |  | **17093** |
| Total Other Income, Net  |  |  | 818 |
| **Income Before Income Taxes** |  |  | **17911** |
| Income Tax Expense |  |  | (3385) |
| **Net Income** |  |  | $**14526** |
|  | **For the Three Months Ended April 30, 2025** | **For the Three Months Ended April 30, 2025** | **For the Three Months Ended April 30, 2025** |
| *(in thousands)* | **Business to Business Products Group** | **Retail and Wholesale Products Group** | **Total** |
| **Net Sales** | $42678 | $72823 | $115501 |
| Cost of Goods Sold | (25141) | (57338) | (82479) |
| **Gross Profit** | **17537** | **15485** | **33022** |
| Compensation & Consultant | (2263) | (2181) | (4444) |
| Advertising | (266) | (1772) | (2038) |
| Other Operating Expenses | (1626) | (1823) | (3449) |
| **Operating Income** | **13382** | **9709** | **23091** |
| Corporate Expenses |  |  | (9187) |
| **Income from Operations** |  |  | **13904** |
| Total Other Income, Net |  |  | 344 |
| **Income Before Income Taxes** |  |  | **14248** |
| Income Tax Expense |  |  | (2604) |
| **Net Income** |  |  | $**11644** |

---

We do not rely on any operating segment asset allocations, and we do not consider them meaningful because of the shared nature of our production facilities; however, we have estimated the segment asset allocations below for those assets for which we can reasonably determine. The unallocated asset category is the remainder of our total assets. The asset allocation is estimated and is not a measure used by our chief operating decision maker about allocating resources to the operating segments or in assessing their performance.

---

| | | |
|:---|:---|:---|
| | **Assets** | **Assets** |
| | **April 30, 2026** | **July 31, 2025** |
| | **(in thousands)** | **(in thousands)** |
| Business to Business Products Group | $**100249** | $104857 |
| Retail and Wholesale Products Group | **214016** | 200644 |
| Unallocated Assets | **94525** | 86176 |
| **Total Assets** | $**408790** | $391677 |

---

------

**11. STOCK-BASED COMPENSATION**

The 2006 Plan permits the grant of stock options, stock appreciation rights, restricted stock, restricted stock units, performance awards and other stock-based and cash-based awards. Our employees and outside directors are eligible to receive grants under the 2006 Plan. The total number of shares of stock subject to grants under the 2006 Plan may not exceed 3,439,000. As of April 30, 2026, there were 1,074,344 shares of Common Stock or Class B Stock available for future grants under this plan.

**Restricted Stock**

All of our non-vested restricted stock as of April 30, 2026 was issued under the 2006 Plan with vesting periods generally between one and five years. We determined the fair value of restricted shares as of the grant date. We recognize the related compensation expense over the period from the date of grant to the date the shares vest.

There were 73,400 and 135,850 restricted shares of Common Stock granted during the nine months ended April 30, 2026, and 2025, respectively. There were no restricted shares of Class B Stock granted during the nine months ended April 30, 2026, and 2025. Stock-based compensation expense was $1.0 million for the three months ended April 30, 2026, and 2025, and was $3.1 million and $2.9 million for the nine months ended April 30, 2026, and 2025, respectively.

A summary of restricted stock transactions is shown below:

---

| | | |
|:---|:---|:---|
| | **Restricted Shares<br>(in thousands)** | **Weighted Average Grant Date Fair Value<br>(per share)** |
| Non-vested restricted stock outstanding at July 31, 2025 | 728 | $28.52 |
| Granted | 73 | $58.18 |
| Vested | (208) | $21.42 |
| Forfeitures | (4) | $36.82 |
| Non-vested restricted stock outstanding at April 30, 2026 | 589 | $34.66 |

---

**12. ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS)**

The following table summarizes the changes in accumulated other comprehensive income (loss) by component as of April 30, 2026 (in thousands):

---

| | | | |
|:---|:---|:---|:---|
| | **Postretirement Health Benefits** | **Cumulative Translation Adjustment** | **Total Accumulated Other Comprehensive Income (Loss)** |
| Balance as of July 31, 2025 | $1205 | $(236) | $969 |
| Other comprehensive income before reclassifications, net of tax |  | 71 | 71 |
| Amounts reclassified from accumulated other comprehensive income, net of tax | (64) |  | (64) |
| Net current-period other comprehensive (loss) income, net of tax | (64) | 71 | 7 |
| Balance as of April 30, 2026 | $1141 | $(165) | $976 |

---

------

**13. RELATED PARTY TRANSACTIONS**

One member of our Board is currently the President and Chief Executive Officer of one of our vendors. Total payments to this vendor for fees and cost reimbursements were $0.1 million and $0.5 million for the three months ended April 30, 2026 and April 30, 2025, respectively, and $0.8 million and $1.0 million for the first nine months of fiscal years 2026, and 2025, respectively. There were no outstanding accounts payable due to that vendor as of either April 30, 2026, or July 31, 2025.

One member of our Board retired from the role of President and Chief Executive Officer of a customer of ours on September 28, 2019, and was party to a post-employment consulting agreement with the customer until September 30, 2025. Total sales to that customer, including sales to its subsidiaries, were $0.1 million for both the three months ended April 30, 2026, and April 30, 2025, and $0.2 million and $0.3 million for the first nine months of fiscal years 2026 and 2025, respectively. There were no outstanding amounts due from that customer as of either April 30, 2026, or July 31, 2025.

------

**ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS**

*The following discussion and analysis of our financial condition and results of operations should be read together with the financial statements and the related notes included herein and our Consolidated Financial Statements, accompanying notes and Management's Discussion and Analysis of Financial Condition and Results of Operations contained in our Annual Report on Form 10-K for the fiscal year ended July 31, 2025. This discussion contains forward-looking statements that involve risks and uncertainties. Our actual results may differ materially from the results discussed in the forward-looking statements. Factors that might cause a difference include, but are not limited to, those discussed herein under "Forward-Looking Statements" and "Risk Factors," and those discussed under Part I, Item 1A, "Risk Factors," of our Annual Report on Form 10-K for the fiscal year ended July 31, 2025.* 

**<u>OVERVIEW</u>**

We develop, mine, manufacture and market sorbent products principally produced from clay minerals, primarily consisting of calcium bentonite, attapulgite and diatomaceous shale. Our principal products include agricultural and horticultural chemical carriers, animal health and nutrition products, cat litter, fluids purification and filtration bleaching clays, industrial and automotive floor absorbents and sports field products. Our products are sold to two primary customer groups, including customers who resell our products as originally produced to the end consumer and other customers who use our products as part of their production process or use them as an ingredient in their final finished product. We have two reportable operating segments based on the different characteristics of our two primary customer groups: the Retail and Wholesale Products Group ("Retail and Wholesale") and the Business to Business Products Group ("Business to Business"), as described in Note 10 of the Notes to the unaudited Condensed Consolidated Financial Statements. Each operating segment is discussed individually below.

RECENT EVENTS AFFECTING THE COMPANY

Over a period of several days in January 2026, the southern and eastern United States was impacted by a significant weather event known as "Winter Storm Fern" that resulted in snow, freezing rain, and ice causing widespread damage and power outages ("Weather Event"). During this time, due to safety concerns and interruptions that we experienced to power, natural gas, and water, we temporarily shut down operations of our facilities in the affected regions, which resulted in reduced production. Our supply chain was also impacted, causing significant delays in delivery of materials and services necessary to resume production. These shutdowns and delays resulted in decreased fixed cost absorption and an increase of backlog in the second quarter of fiscal year 2026. All operations have since resumed normal activity and the backlog has decreased by $2.2 million at the end of the third quarter when compared to the prior quarter. We define backlog as purchase orders that we have received from customers and that we have accepted, but that have not shipped by the customers' requested ship dates.

While ongoing geopolitical tensions and conflict in the Middle East have contributed to broader market volatility, these conditions did not have a direct, material impact on our results for the current quarter. However, continued uncertainty in the region may lead to increased input and transportation costs in future periods. The Company continues to closely monitor developments and assess potential impacts on operations and costs.

------

**<u>NINE MONTHS ENDED APRIL 30, 2026 COMPARED TO</u>**

**<u>NINE MONTHS ENDED APRIL 30, 2025</u>**

CONSOLIDATED RESULTS

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **For the Nine Months Ended April 30,** | **For the Nine Months Ended April 30,** | **For the Nine Months Ended April 30,** | **For the Nine Months Ended April 30,** |
| **(in thousands)** | **2026** | **2025** | **$** <br>**Change** | **%** <br>**Change** |
| **Consolidated Results** |  |  |  |  |
| &nbsp;&nbsp;Net Sales | $364552 | $360360 | $4192 | 1% |
| &nbsp;&nbsp;Gross Profit | $101525 | $108250 | $(6725) | (6)% |
| &nbsp;&nbsp;SG&A | $(51785) | $(55674) | $3889 | (7)% |
| &nbsp;&nbsp;Income from Operations  | $49740 | $52576 | $(2836) | (5)% |
| &nbsp;&nbsp;Net income  | $42551 | $40941 | $1610 | 4% |
| **Business to Business** |  |  |  |  |
| &nbsp;&nbsp;Net Sales | $130104 | $134509 | $(4405) | (3)% |
| &nbsp;&nbsp;Operating Income  | $38392 | $44814 | $(6422) | (14)% |
| **Retail & Wholesale** |  |  |  |  |
| &nbsp;&nbsp;Net Sales | $234448 | $225851 | $8597 | 4% |
| &nbsp;&nbsp;Operating Income  | $34470 | $34414 | $56 | —% |

---

Consolidated net sales for the nine months ended April 30, 2026 were $364.6 million, representing a 1% increase compared to net sales of $360.4 million for the nine months ended April 30, 2025. The increase was driven primarily by higher volumes of cat litter and agricultural and horticultural products, when compared to the same period in fiscal year 2025. Further details of the drivers are discussed below in the segment analysis.

Consolidated gross profit in the nine months ended April 30, 2026 was $101.5 million, a decrease of $6.7 million, or 6%, from gross profit of $108.3 million in the nine months ended April 30, 2025. Gross margin (defined as gross profit as a percentage of net sales) in the nine months ended April 30, 2026 decreased to 27.8% from 30.0% in the nine months ended April 30, 2025, driven primarily by higher per ton costs. For the nine months ended April 30, 2026, the overall domestic per ton cost of goods sold increased 4% compared to the same period of fiscal year 2025. The increase was primarily driven by higher per ton manufacturing costs which increased 8% when compared to nine months ended April 30, 2025. Labor was the largest contributor to this increase, along with higher costs for repairs, depreciation, purchased materials, and natural gas. These increases were slightly offset by a 3% decrease in per ton transportation costs, and 1% decrease in per ton packaging costs for the nine months ended April 30, 2026, when compared to the nine months ended April 30, 2025.

Total SG&A expenses of $51.8 million for the nine months ended April 30, 2026 were $3.9 million, or 7%, lower compared to $55.7 million for the nine months ended April 30, 2025. The decrease was driven by a $3.5 million reduction in corporate unallocated expenses, primarily as a result of a lower incentive bonus accrual and lower corporate human resource costs. The additional $0.4 million decrease in SG&A expenses at the operating segments level is discussed below.

Total other income, net was $1.7 million for the nine months ended April 30, 2026, roughly a $3.5 million gain compared to total other expenses, net of $1.9 million in the same period of fiscal year 2025. This gain was driven by a number of items including, $0.9 million due to a reduction in the estimated landfill modification costs recognized in fiscal year 2026 compared to an increase in the estimated cost recognized during the nine months ended April 30, 2025 and $0.8 million due to foreign exchange gains. The gain was also in part driven by the positive outcome of a confidential legal settlement in the matter of Oil-Dri Corporation of America vs. Entera Animal Health, et al.

Tax expense was $8.8 million for the nine months ended April 30, 2026 compared to $9.8 million for the nine months ended April 30, 2025, mainly due to the impact of discrete items. We used an effective tax rate of 17% for the nine months ended April 30, 2026 compared to a 19% effective tax rate in the same period of fiscal year 2025. We adjust our effective tax rate based on expected annual taxable income and our assessment of various tax adjustments, including depletion and discrete items.

Our unaudited Condensed Consolidated Balance Sheet as of April 30, 2026 and our unaudited Condensed Consolidated Statement of Cash Flows for the nine months ended April 30, 2026 show a $12.5 million increase in total cash and cash equivalents from fiscal year-end 2025. The increase was driven primarily by positive cash flow from operations, partially offset by investing and financing activities. Refer to the "Liquidity and Capital Resources" section below for more details.

------

BUSINESS TO BUSINESS PRODUCTS GROUP

---

| | | | | |
|:---|:---|:---|:---|:---|
| (in thousands) | **For the Nine Months Ended April 30,** | **For the Nine Months Ended April 30,** | **For the Nine Months Ended April 30,** | **For the Nine Months Ended April 30,** |
| **Business to Business Products Group** | **2026** | **2025** | **$ Change** | **% Change** |
| &nbsp;&nbsp;Agricultural and Horticultural | $**36615** | $32396 | $4219 | 13% |
| &nbsp;&nbsp;Fluids Purification | **77180** | 82384 | (5204) | (6)% |
| &nbsp;&nbsp;Animal Health & Nutrition  | **16309** | 19729 | (3420) | (17)% |
| **Net Sales** | $**130104** | $134509 | $(4405) | (3)% |
| Cost of Goods Sold | $**(79334)** | $(77672) | $(1662) | 2% |
| **Gross Profit** | $**50770** | $56837 | $(6067) | (11)% |
| SG&A | $**(12378)** | $(12023) | $(355) | 3% |
| **Operating Income** | $**38392** | $44814 | $(6422) | (14)% |

---

Net sales of the Business to Business Products Group for the nine months ended April 30, 2026 decreased $4.4 million, or 3%, compared to the nine months ended April 30, 2025, driven primarily by a reduction in sales of our fluids purification and animal health products, partially offset by an increase in sales of our agricultural and horticultural products. Net sales of our fluids purification products for the nine months ended April 30, 2026 decreased $5.2 million, or 6%, compared to the nine months ended April 30, 2025. This decrease was due to lower volumes, primarily of our products used in renewable diesel filtration, which were significantly higher in fiscal year 2025 when several new customers began operations in new plants. Net sales of our animal health & nutrition products for the nine months ended April 30, 2026 decreased $3.4 million, or 17%, compared to the nine months ended April 30, 2025, due to lower volume primarily driven by a temporary loss of a key customer at one of our distributors. Net sales of our agricultural and horticultural products for the nine months ended April 30, 2026 increased $4.2 million, or 13%, compared to the nine months ended April 30, 2025, due to a combination of favorable mix and higher volume.

Gross profit decreased 11% in the nine months ended April 30, 2026 compared to the nine months ended April 30, 2025. This decrease was mainly due to lower sales resulting in unfavorable fixed cost absorption and higher per ton manufacturing costs. For the nine months ended April 30, 2026, the overall Business to Business domestic per ton cost of goods sold increased 5% compared to the same period of fiscal year 2025. The increase was primarily driven by higher per ton manufacturing costs, including materials, which increased 9% when compared to nine months ended April 30, 2025. Per ton transportation and packaging costs remained flat for the nine months ended April 30, 2026, when compared to the nine months ended April 30, 2025. SG&A expenses increased by $0.4 million, or 3%, for the nine months ended April 30, 2026 compared to the nine months ended April 30, 2025, primarily driven by higher compensation costs.

RETAIL AND WHOLESALE PRODUCTS GROUP

---

| | | | | |
|:---|:---|:---|:---|:---|
| (in thousands) | **For the Nine Months Ended April 30,** | **For the Nine Months Ended April 30,** | **For the Nine Months Ended April 30,** | **For the Nine Months Ended April 30,** |
| **Retail and Wholesale Products Group** | **2026** | **2025** | **$ Change** | **% Change** |
| &nbsp;&nbsp;Cat Litter | $**198895** | $190656 | $8239 | 4% |
| &nbsp;&nbsp;Industrial and Sports | **35553** | 35195 | 358 | 1% |
| **Net Sales** | $**234448** | $225851 | $8597 | 4% |
| Cost of Goods Sold | $**(183693)** | $(174438) | $(9255) | 5% |
| **Gross Profit** | $**50755** | $51413 | $(658) | (1)% |
| SG&A | $**(16285)** | $(16999) | $714 | (4)% |
| **Operating Income** | $**34470** | $34414 | $56 | —% |

---

Net sales of the Retail and Wholesale Products Group for the nine months ended April 30, 2026 increased $8.6 million, or 4%, compared to the nine months ended April 30, 2025, mainly due to an increase in cat litter sales. Net sales of co-packaged cat litter products increased 43% in the nine months ended April 30, 2026, compared to the nine months ended April 30, 2025. This increase was driven primarily by higher volumes as we expanded our co-packaged offerings to include lightweight cat litter. Domestic cat litter net sales, excluding co-packaged cat litter, were $170.2 million for the nine months ended April 30, 2026, an increase of $1.9 million, or 1%, when compared to the nine months ended April 30, 2025, mainly driven by higher volumes of

------

crystal cat litter products. Net sales of our domestic industrial and sports products were $33.8 million for the nine months ended April 30, 2026, an increase of $0.6 million, or 2%, when compared to the nine months ended April 30, 2025, mainly driven by higher prices to offset elevated costs including higher transportation costs. Net sales by our subsidiary in Canada, which include both our cat litter and industrial products, increased $0.2 million, or 2%, for the nine months ended April 30, 2026, when compared to the nine months ended April 30, 2025.

Gross profit decreased 1% in the nine months ended April 30, 2026, compared to the nine months ended April 30, 2025. This decrease was mainly due to higher per ton manufacturing costs. For the nine months ended April 30, 2026, the overall Retail and Wholesale domestic per ton cost of goods sold increased 4% compared to the same period of fiscal year 2025. The increase was primarily driven by higher per ton manufacturing costs, including materials, which increased 8% when compared to nine months ended April 30, 2025. This increase was partially offset by a 5% reduction in per ton transportation and 2% reduction in per ton packaging costs. SG&A expenses decreased $0.7 million, or 4%, during the nine months ended April 30, 2026, compared to the nine months ended April 30, 2025, primarily due to timing of advertising spend.

FOREIGN OPERATIONS

Foreign operations include our subsidiaries in Canada and the Netherlands, which are reported in the Retail and Wholesale Products Group, and our subsidiaries in the United Kingdom ("UK"), Mexico, China and Indonesia, which are reported in the Business to Business Products Group. Net sales by our foreign subsidiaries for the nine months ended April 30, 2026 were $14.6 million, a decrease of $0.3 million compared to net sales of $14.9 million in the same period ended April 30, 2025, driven primarily by a decrease in sales volume in Mexico. Net sales by our foreign subsidiaries represented 4% of our consolidated net sales for both the nine months ended April 30, 2026, and April 30, 2025.

Our foreign subsidiaries reported net income of $0.3 million for the nine months ended April 30, 2026, compared to net loss of $0.1 million in the nine months ended April 30, 2025. The increase in net income was primarily driven by the preliminary foreign VAT assessment recognized in fiscal year 2025.

Identifiable assets of our foreign subsidiaries as of April 30, 2026 were $10.3 million, compared to $9.0 million as of July 31, 2025.

**<u>THREE MONTHS ENDED APRIL 30, 2026 COMPARED TO</u>**

**<u>THREE MONTHS ENDED APRIL 30, 2025</u>**

CONSOLIDATED RESULTS

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **For the Three Months Ended April 30,** | **For the Three Months Ended April 30,** | **For the Three Months Ended April 30,** | **For the Three Months Ended April 30,** |
| **(in thousands)** | **2026** | **2025** | **$** <br>**Change** | **%** <br>**Change** |
| **Consolidated Results** |  |  |  |  |
| &nbsp;&nbsp;Net Sales | $126329 | $115501 | $10828 | 9% |
| &nbsp;&nbsp;Gross Profit | $33728 | $33022 | $706 | 2% |
| &nbsp;&nbsp;SG&A | $(16635) | $(19118) | $2483 | (13)% |
| &nbsp;&nbsp;Income from Operations  | $17093 | $13904 | $3189 | 23% |
| &nbsp;&nbsp;Net income  | $14526 | $11644 | $2882 | 25% |
| **Business to Business** |  |  |  |  |
| &nbsp;&nbsp;Net Sales | $43841 | $42678 | $1163 | 3% |
| &nbsp;&nbsp;Operating Income  | $12959 | $13382 | $(423) | (3)% |
| **Retail & Wholesale** |  |  |  |  |
| &nbsp;&nbsp;Net Sales | $82488 | $72823 | $9665 | 13% |
| &nbsp;&nbsp;Operating Income  | $11299 | $9709 | $1590 | 16% |

---

Consolidated net sales for the third quarter of fiscal year 2026 were $126.3 million, a 9% increase compared to net sales of $115.5 million for the third quarter of fiscal year 2025, primarily driven by higher volume of cat litter within our Retail and Wholesale operating segment.

------

Consolidated gross profit for the third quarter of fiscal year 2026 was $33.7 million, an increase of 2% when compared to $33.0 million for the third quarter of fiscal year 2025, mainly due to higher net sales. Our gross margin (defined as gross profit as a percentage of net sales) decreased to 26.7% from 28.6% in the third quarter of fiscal year 2026 compared to the third quarter of fiscal year 2025. This decrease was mainly driven by higher per ton costs of goods sold. Domestic per ton cost of goods sold increased 6%, due to a 9% increase in per ton manufacturing costs when compared to the same period in fiscal year 2025. The largest driver of this increase was purchased materials, along with higher repair, natural gas and labor costs. There was also a 3% increase in per ton packaging, and 1% higher transportation costs. These increases were also partially driven by additional costs incurred during recovery from the Weather Event.

Total SG&A expenses of $16.6 million for the third quarter of fiscal year 2026 decreased by $2.5 million, or 13%, compared to $19.1 million for the same period of fiscal year 2025. This decrease was primarily due to unallocated corporate expenses which decreased $2.0 million, or 22%, compared to the same period in fiscal year 2025, primarily as a result of a lower corporate bonus accrual. SG&A expenses at the operating segments level also decreased and are discussed below in the discussion of our segments' operating income.

Total net other income was $0.8 million for the third quarter of fiscal year 2026, compared to $0.3 million for the third quarter of fiscal year 2025.

Tax expense was $3.4 million for the third quarter of fiscal year 2026 compared to $2.6 million for the third quarter of fiscal year 2025, mainly due to higher pre-tax income. We used an effective tax rate of 19% in the third quarter of fiscal year 2026, compared to an 18% effective tax rate in the third quarter of fiscal year 2025. We adjust our effective tax rate quarterly based on expected annual taxable income and our assessment of various tax adjustments, including depletion and discrete items.

BUSINESS TO BUSINESS PRODUCTS GROUP

---

| | | | | |
|:---|:---|:---|:---|:---|
| (in thousands) | **For the Three Months Ended April 30,** | **For the Three Months Ended April 30,** | **For the Three Months Ended April 30,** | **For the Three Months Ended April 30,** |
| **Business to Business Products Group** | **2026** | **2025** | **$ Change** | **% Change** |
| &nbsp;&nbsp;Agricultural and Horticultural | $**12442** | $11639 | $803 | 7% |
| &nbsp;&nbsp;Fluids Purification | **25040** | 25269 | (229) | (1)% |
| &nbsp;&nbsp;Animal Health & Nutrition | **6359** | 5770 | 589 | 10% |
| **Net Sales** | $**43841** | $42678 | $1163 | 3% |
| Cost of Goods Sold | $**(26694)** | $(25141) | $(1553) | 6% |
| **Gross Profit** | $**17147** | $17537 | $(390) | (2)% |
| SG&A | $**(4188)** | $(4155) | $(33) | 1% |
| **Operating Income** | $**12959** | $13382 | $(423) | (3)% |

---

Net sales of the Business to Business Products Group increased $1.2 million, or 3%, in the third quarter of fiscal year 2026, compared to the same period in 2025, driven primarily by agricultural and horticultural and animal health sales, offset partially by a slight decrease in fluids purification sales. Net sales of our agricultural and horticultural products in the third quarter of fiscal year 2026 increased $0.8 million, or 7%, compared to the third quarter of fiscal year 2025, due to higher volume from increased demand by new and existing customers. Net sales of our animal health and nutrition products in the third quarter of fiscal year 2026 increased $0.6 million, or 10%, compared to the third quarter of fiscal year 2025, driven by higher volumes due to increased demand, including new end-users and partial recovery of sales from a previously lost customer at one of our distributors. Net sales of our fluids purification products in the third quarter decreased $0.2 million, or 1%, compared to the third quarter of fiscal year 2025.

Gross profit for the Business to Business Products Group decreased 2% in the third quarter of fiscal year 2026, compared to the same period in 2025, mainly driven by higher manufacturing costs. Domestic per ton manufacturing costs for Business to Business products increased 8%. This was partially offset by lower per ton packaging cost, which decreased 4%. Per ton freight cost in the third quarter remained flat compared to the same period in fiscal 2025. Total SG&A expenses for the Business to Business Products Group in the third quarter of fiscal year 2026 remained flat compared to the same period of fiscal year 2025.

------

RETAIL AND WHOLESALE PRODUCTS GROUP

---

| | | | | |
|:---|:---|:---|:---|:---|
| (in thousands) | **For the Three Months Ended April 30,** | **For the Three Months Ended April 30,** | **For the Three Months Ended April 30,** | **For the Three Months Ended April 30,** |
| **Retail and Wholesale Products Group** | **2026** | **2025** | **$ Change** | **% Change** |
| &nbsp;&nbsp;Cat Litter | $**69219** | $59743 | $9476 | 16% |
| &nbsp;&nbsp;Industrial and Sports | **13269** | 13080 | 189 | 1% |
| **Net Sales** | $**82488** | $72823 | $9665 | 13% |
| Cost of Goods Sold | $**(65907)** | $(57338) | $(8569) | 15% |
| **Gross Profit** | $**16581** | $15485 | $1096 | 7% |
| SG&A | $**(5282)** | $(5776) | $494 | (9)% |
| **Operating Income** | $**11299** | $9709 | $1590 | 16% |

---

Net sales of the Retail and Wholesale Products Group increased $9.7 million, or 13%, in the third quarter of fiscal year 2026, compared to the same period in 2025, primarily due to cat litter sales. Domestic cat litter net sales, excluding sales of co-packaged cat litter, were $57.9 million for the third quarter of fiscal year 2026, an increase of $5.2 million when compared to the third quarter of fiscal year 2025. This was primarily driven by higher volume, including sales shifted into the third quarter due to delays caused by the Weather Event. Net sales of co-packaged cat litter products increased 94% compared to the third quarter of fiscal year 2025, due to higher volumes as we expanded our co-packaged offerings to include lightweight cat litter. Net sales of our domestic industrial and sports products in the third quarter of fiscal year 2026 were $12.7 million, an increase of $0.3 million, or 3%, when compared to the third quarter of fiscal year 2025, mainly driven by the higher pricing to offset elevated costs including higher transportation costs. Net sales by our subsidiary in Canada, which include both our cat litter and industrial products, in the third quarter of fiscal year 2026, increased $0.1 million, or 2%, compared to the same period in 2025.

Gross profit increased 7% in the third quarter of fiscal year 2026, compared to the same period in 2025. This increase is primarily due to higher net sales which offset the impact of higher per ton cost of goods sold. Domestic per-ton manufacturing costs, including materials, increased by 9%. Per ton transportation and packaging costs increased 4% and 2%, respectively. SG&A expenses for the Retail and Wholesale Products Group decreased by $0.5 million, or 9%, during the third quarter of fiscal year 2026, compared to the same period in fiscal year 2025, primarily due to timing of advertising spend.

FOREIGN OPERATIONS

Foreign operations include our subsidiaries in Canada and the Netherlands, which are reported in the Retail and Wholesale Products Group, and our subsidiaries in the UK, Mexico, China and Indonesia, which are reported in the Business to Business Products Group. Net sales by our foreign subsidiaries during the third quarter of fiscal year 2026 were $4.7 million, a decrease of $0.1 million compared to net sales of $4.8 million during the same period of fiscal year 2025. This decrease was driven primarily by a $0.2 million decrease in net sales in Mexico, partially offset by a $0.1 million increase in net sales in Canada. Net sales by our foreign subsidiaries represented 4% of our consolidated net sales during the third quarter of both fiscal years 2026 and 2025.

Our foreign subsidiaries reported net income of $0.1 million for the third quarter of fiscal year 2026 as compared to $0.2 million in the third quarter of fiscal year 2025.

**<u>LIQUIDITY AND CAPITAL RESOURCES</u>**

Our principal liquidity needs are to fund our capital requirements, including funding working capital needs; purchasing and upgrading equipment, facilities, information systems, and real estate; supporting new product development; investing in infrastructure; repurchasing stock; paying dividends; and, from time to time, business acquisitions, and funding our debt service requirements. During the nine months ended April 30, 2026, we principally funded these short and long-term capital requirements using cash from current operations as well as cash generated from previous borrowings under our Credit Agreement and Series B, C and D Senior Notes issued under the Note Agreement. See Note 8 of the Notes to the unaudited Condensed Consolidated Financial Statements in this Quarterly Report on Form 10-Q for further information relating to our existing borrowings.

We believe that cash flow from operations, availability under our Note Agreement and revolving credit facility under our Credit Agreement, current cash balances and our ability to obtain other financing, if necessary, will provide sufficient liquidity for

------

foreseeable working capital needs, capital expenditures at existing facilities, deferred compensation payouts, dividend payments and debt service obligations for the foreseeable future.

We continually evaluate our liquidity position and anticipated cash needs, as well as the financing options available to obtain additional cash reserves. Our ability to fund operations, to make planned capital expenditures, to make scheduled debt payments and to remain in compliance with all financial covenants under debt agreements, including, but not limited to, the Credit Agreement, depends on our future operating performance, which, in turn, is subject to prevailing economic conditions and to financial, business and other factors. The timing and size of any new business ventures or acquisitions that we complete may also impact our cash requirements.

Cash and cash equivalents totaled $62.9 million and $36.5 million as of April 30, 2026, and 2025, respectively. The following table sets forth certain elements of our unaudited Condensed Consolidated Statements of Cash Flows (in thousands):

---

| | | |
|:---|:---|:---|
| | **For the Nine Months Ended April 30,** | **For the Nine Months Ended April 30,** |
| | **2026** | **2025** |
| Net cash provided by operating activities | $**53208** | $54988 |
| Net cash used in investing activities | **(20606)** | (24509) |
| Net cash used in financing activities | **(20163)** | (18523) |
| Effect of exchange rate changes on cash and cash equivalents | **44** | 38 |
| Net increase in cash and cash equivalents | $**12483** | $11994 |

---

*Net cash provided by operating activities*

In addition to net income, as adjusted for depreciation and amortization and other non-cash operating activities, the primary sources and uses of operating cash flows for the nine months ended April 30, 2026, were as follows:

Accounts receivable, net of allowances increased by $6.2 million in the nine months ended April 30, 2026. The increase in accounts receivable was driven primarily by net sales and timing of collections.

Inventory increased by $0.8 million in the nine months ended April 30, 2026, mainly due to the building of finished goods inventory and purchases of other additives to meet anticipated demand.

Excluding the impact of payments related to capital expenditures, accounts payable decreased by $0.6 million in the nine months ended April 30, 2026. The decrease was mainly due to the timing of payments, cost of goods and services we purchase, production volume levels and vendor payment terms. In the nine months ended April 30, 2026, there was a $2.3 million decrease in accounts payable related to capital expenditures recognized as cash used in investing activities as compared to the nine months ended April 30, 2025.

Excluding the impact of payments made related to capital expenditures, accrued expenses decreased $5.5 million in the nine months ended April 30, 2026. The decrease was mainly due to the payout of annual bonuses and other miscellaneous expenses which fluctuate due to timing of payments, changes in the cost of goods and services we purchase, production volume levels, and vendor payment terms, including freight. In the nine months ended April 30, 2026, there was a $1.0 million decrease in accrued expenses related to capital expenditures recognized as cash used in investing activities as compared to the nine months ended April 30, 2025.

*Net cash used in investing activities*

Cash used in investing activities totaled $20.6 million in the nine months ended April 30, 2026, primarily driven by capital expenditures. During this period, we continued to invest in expanding our plant equipment and enhance our facilities to improve manufacturing efficiency and support customer demand.

*Net cash used in financing activities*

Cash used in financing activities of $20.2 million in the nine months ended April 30, 2026 included $12.5 million for stock repurchases and $7.6 million for dividend payments.

------

*Other*

Total cash balances held by our foreign subsidiaries were $7.1 million as of April 30, 2026, compared to $4.7 million as of July 31, 2025.

As of April 30, 2026, we had remaining authority to repurchase 172,261 shares of Common Stock and 208,197 shares of Class B Stock under a repurchase plan approved by our Board. Repurchases may be made on the open market (pursuant to Rule 10b5-1 plans or otherwise) or in negotiated transactions. The timing, number and manner of share repurchases will be determined by our management pursuant to the repurchase plan approved by our Board.

**<u>CRITICAL ACCOUNTING POLICIES AND ESTIMATES</u>**

This discussion and analysis of financial condition and results of operations is based on our unaudited Condensed Consolidated Financial Statements, which have been prepared in accordance with U.S. GAAP for interim financial information and in compliance with instructions to Form 10-Q and Article 10 of Regulation S-X. The preparation of these financial statements requires the use of estimates and assumptions related to the reporting of assets, liabilities, revenues, expenses and related disclosures. In preparing these financial statements, we have made our best estimates and judgments of certain amounts included in the financial statements. Estimates and assumptions are revised periodically. Actual results could differ from these estimates. See the information concerning our critical accounting policies included under "Management's Discussion of Financial Condition and Results of Operations" in our Annual Report on Form 10-K for the fiscal year ended July 31, 2025.

**ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK**

There has been no material change in our exposure to market risk from that discussed in our Annual Report on Form 10-K for the fiscal year ended July 31, 2025.

**ITEM 4. CONTROLS AND PROCEDURES**

**Evaluation of Disclosure Controls and Procedures**

Management conducted an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rule 13a-15(e) under the Securities Exchange Act of 1934 (the "Exchange Act")) as of the end of the period covered by this Quarterly Report on Form 10-Q. The controls evaluation was conducted under the supervision and with the participation of management, including our Chief Executive Officer ("CEO") and Chief Financial Officer ("CFO"). Based upon the controls evaluation, our CEO and CFO have concluded that, as of the end of the period covered by this report, our disclosure controls and procedures were effective.

**Changes in Internal Control over Financial Reporting**

There were no changes in our internal control over financial reporting (as defined in Rule 13a-15(f) under the Exchange Act) that occurred during the fiscal quarter ended April 30, 2026 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

------

**Inherent Limitations on Effectiveness of Controls**

Our management, including the CEO and CFO, do not expect that our disclosure controls and procedures or our internal control over financial reporting will prevent or detect all errors and all fraud. A control system, no matter how well designed and operated, can provide only reasonable, not absolute, assurance that the control system's objectives will be met. The design of a control system must reflect the fact that there are resource constraints, and the benefits of controls must be considered relative to their costs. Further, because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that misstatements due to error or fraud will not occur or that all control issues and instances of fraud, if any, within the Company have been detected. These inherent limitations include the realities that judgments in decision-making can be faulty and that breakdowns can occur because of simple error or mistake. Controls can also be circumvented by the individual acts of some persons, by collusion of two or more people, or by management override of the controls. The design of any system of controls is based in part on certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions. Projections of any evaluation of controls effectiveness to future periods are subject to risks. Over time, controls may become inadequate because of changes in conditions or deterioration in the degree of compliance with policies or procedures.

**PART II – OTHER INFORMATION**

Items 1, 3, and 5 of this Part II are either inapplicable or are answered in the negative and are omitted pursuant to the instructions to Part II of Form 10-Q.

**ITEM 1A. RISK FACTORS**

Our operations and financial results are subject to various risks and uncertainties, including those described in Part I, Item 1A, "Risk Factors," of our Annual Report on Form 10-K for the fiscal year ended July 31, 2025. There have been no material changes to our risk factors since our Annual Report on Form 10-K for the fiscal year ended July 31, 2025.

------

**ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS**

During the three months ended April 30, 2026, we did not sell any equity securities which were not registered under the Securities Act of 1933, as amended. The following table summarizes our Common Stock purchases by or on behalf of the Company or any affiliated purchaser (as defined in Rule 10b-18(a)(3) under the Exchange Act) during this period.

---

| | | | | |
|:---|:---|:---|:---|:---|
| **ISSUER PURCHASES OF EQUITY SECURITIES**<sup>1, 2</sup> | **ISSUER PURCHASES OF EQUITY SECURITIES**<sup>1, 2</sup> | **ISSUER PURCHASES OF EQUITY SECURITIES**<sup>1, 2</sup> | **ISSUER PURCHASES OF EQUITY SECURITIES**<sup>1, 2</sup> | **ISSUER PURCHASES OF EQUITY SECURITIES**<sup>1, 2</sup> |
|<br>**Period** | **(a)**<br>**Total Number of Shares Purchased**<sup>3</sup> | **(b)**<br>**Average Price Paid per Share** | **(c)**<br>**Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs** | **(d)**<br>**Maximum Number of Shares that may yet be Purchased Under Plans or Programs**<sup>4</sup> |
| **Common Stock** | **Common Stock** | **Common Stock** | **Common Stock** | **Common Stock** |
| February 1, 2026 to February 28, 2026 | 1809 | $67.84 |  | 172933 |
| March 1, 2026 to March 31, 2026 |  | $— |  | 172933 |
| April 1, 2026 to <br>April 30, 2026 | 672 | $74.38 |  | 172261 |

---

<sup>1</sup> The table summarizes repurchases of (and remaining authority to repurchase) shares of our Common Stock and Class B Stock. No shares of our Class A Common Stock are currently outstanding. Descriptions of our Common Stock, Class B Stock and Class A Common Stock are contained in Exhibit 4.1 of our Annual Report on Form 10-K for the fiscal year ended July 31, 2025.

<sup>2</sup> The figures in the table reflect transactions according to the settlement dates. For the purposes of our unaudited Condensed Consolidated Financial Statements included in this report, the impact of repurchases are recorded according to the settlement dates.

<sup>3</sup> Includes 1,809 shares and 672 shares of Common Stock which were surrendered by employees to pay taxes related to restricted stock awards during the periods of February 1, 2026 to February 28, 2026 and April 1, 2026 to April 30, 2026, respectively.

<sup>4</sup> Our Board authorized the repurchase of 750,000 shares of Common Stock on March 11, 2019. This authorization, which was announced on March 11, 2019, does not have a stated expiration date. The share numbers in this column indicate the number of shares of Common Stock that may yet be repurchased under this authorization. Repurchases may be made on the open market (pursuant to Rule 10b5-1 plans or otherwise) or in negotiated transactions. The timing, number and manner of share repurchases will be determined by management.

**ITEM 4. MINE SAFETY DISCLOSURES**

Our mining operations are subject to regulation by the Mine Safety and Health Administration under authority of the Federal Mine Safety and Health Act of 1977, as amended. Information concerning mine safety violations or other regulatory matters required by section 1503(a) of the Dodd-Frank Wall Street Reform and Consumer Protection Act and Item 104 of Regulation S-K are included in Exhibit 95 to this Quarterly Report on Form 10-Q.

------

**ITEM 6. EXHIBITS**

---

| | | |
|:---|:---|:---|
| Exhibit<br>No. | Description | SEC Document Reference |
| 10.1 | <u>[Second Amendment, effective April 3, 2026, to the Oil-Dri Corporation of America 2005 Deferred Compensation Plan (as amended and restated effective January 1, 2008).](https://www.sec.gov/Archives/edgar/data/74046/000162828026023675/secondamendmenttothedeferr.htm)</u> | Incorporated by reference to Exhibit 10.1 to Oil-Dri Corporation of America's Current Report on Form 8-K filed on April 3, 2026 |
| 10.2 | <u>[Form of Oil-Dri Corporation of America 2006 Long Term Incentive Plan Employee Restricted Stock Agreement for Class A Common Stock.](https://www.sec.gov/Archives/edgar/data/74046/000162828026023675/restrictedstockawardagreem.htm)</u> | Incorporated by reference to Exhibit 10.2 to Oil-Dri Corporation of America's Current Report on Form 8-K filed on April 3, 2026 |
| 10.3 | <u>[F](https://www.sec.gov/Archives/edgar/data/74046/000162828026023675/restrictedstockawardagreemc.htm)[orm of Oil-Dri Corporation of America 2006 Long Term Incentive Plan Employee Restricted Stock Agreement for Common Stock.](https://www.sec.gov/Archives/edgar/data/74046/000162828026023675/restrictedstockawardagreemc.htm)</u> | Incorporated by reference to Exhibit 10.3 to Oil-Dri Corporation of America's Current Report on Form 8-K filed on April 3, 2026 |
| 10.4 | <u>[Form of Oil-Dri Corporation of America 2006 Long Term Incentive Plan Employee Restricted Stock Agreement for Class B Stock.](https://www.sec.gov/Archives/edgar/data/74046/000162828026023675/restrictedstockawardagreema.htm)</u> | Incorporated by reference to Exhibit 10.4 to Oil-Dri Corporation of America's Current Report on Form 8-K filed on April 3, 2026 |
| 10.5 | <u>[Form of Oil-Dri Corporation of America 2006 Long Term Incentive Plan Director Restricted Stock Agreement for Common Stock.](https://www.sec.gov/Archives/edgar/data/74046/000162828026023675/restrictedstockawardagreemb.htm)</u> | Incorporated by reference to Exhibit 10.5 to Oil-Dri Corporation of America's Current Report on Form 8-K filed on April 3, 2026 |
| 31 | <u>[Certifications pursuant to Rule 13a–14(a) or Rule 15d-14(a) under the Securities Exchange Act of 1934, as amended.](odcex3104302026.htm)</u> | Filed herewith. |
| 32 | <u>[Certifications pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.](odcex3204302026.htm)</u> | Furnished herewith. |
| 95 | <u>[Mine Safety Disclosures](odcex9504302026.htm)</u>. | Filed herewith. |
| 101.SCH | XBRL Taxonomy Extension Schema Document | Filed herewith. |
| 101.CAL | XBRL Taxonomy Extension Calculation Linkbase Document | Filed herewith. |
| 101.DEF | XBRL Taxonomy Extension Definition Linkbase Document | Filed herewith. |
| 101.LAB | XBRL Taxonomy Extension Labels Linkbase Document | Filed herewith. |
| 101.PRE | XBRL Taxonomy Extension Presentation Linkbase | Filed herewith. |
| 104 | Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101) | Filed herewith. |

---

Note: Stockholders may receive copies of the above listed exhibits, without fee, by written request to Investor Relations, Oil-Dri Corporation of America, 410 North Michigan Avenue, Suite 400, Chicago, Illinois 60611-4213, by telephone at (312) 321-1515 or by e-mail to info@oildri.com.

------

<u>SIGNATURES</u>

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

OIL-DRI CORPORATION OF AMERICA

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(Registrant)

BY <u>/s/ Daniel S. Jaffee&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u> 

Daniel S. Jaffee

Chairman, President and Chief Executive Officer

BY <u>/s/ Susan M. Kreh&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u> 

Susan M. Kreh

Chief Financial Officer

Dated: June 8, 2026

## Ex-31

**Exhibit 31:** 

**CERTIFICATIONS PURSUANT TO RULE 13A-14(A)/15D-14(A) UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED** 

**Certification of Principal Executive Officer** 

**(Section 302 of the Sarbanes-Oxley Act of 2002)** 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;I.I, Daniel S. Jaffee, certify that:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a.I have reviewed this quarterly report on Form 10-Q of Oil-Dri Corporation of America (the "registrant");

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;d.The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;i.Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;ii.Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;iii.Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;iv.Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;e.The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;i.All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;ii.Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

---

| | |
|:---|:---|
| Date: | June 8, 2026 |
| By: | /s/ Daniel S. Jaffee |
|  | Daniel S. Jaffee <br>Chairman, President and Chief Executive Officer |

---

------

**Exhibit 31 (continued):**

**Certification of a Principal Financial Officer** 

**(Section 302 of the Sarbanes-Oxley Act of 2002)** 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;I.I, Susan M. Kreh, certify that:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.I have reviewed this quarterly report on Form 10-Q of Oil-Dri Corporation of America (the "registrant");

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a.Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b.Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c.Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;d.Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a.All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b.Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

---

| | |
|:---|:---|
| Date: | June 8, 2026 |
| By: | /s/ Susan M. Kreh |
|  | Susan M. Kreh<br>Chief Financial Officer |

---

## Ex-32

**Exhibit 32:** 

**CERTIFICATIONS PURSUANT TO 18 U.S.C. SECTION 1350 AS ADOPTED PURSUANT TO** 

**THE SARBANES-OXLEY ACT OF 2002 CERTIFICATION** 

**Certification** 

Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned officer of Oil-Dri Corporation of America (the "Company") hereby certifies that to the best of my knowledge the Company's Quarterly Report on Form 10-Q for the quarter ended April 30, 2026 (the "Report") fully complies with the requirements of Section 13(a) or 15(d), as applicable, of the Securities Exchange Act of 1934 and that the information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company.

---

| | |
|:---|:---|
| Dated: | June 8, 2026 |
| /s/ Daniel S. Jaffee | /s/ Daniel S. Jaffee |
| Name: Daniel S. Jaffee <br>Title: Chairman, President and Chief Executive Officer | Name: Daniel S. Jaffee <br>Title: Chairman, President and Chief Executive Officer |

---

A signed original of this written statement required by Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

The foregoing certification is being furnished solely pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (Section 1350, Chapter 63 of Title 18, United States Code) and is not being filed as part of the Report or as a separate disclosure document.

**Certification**

Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned officer of Oil-Dri Corporation of America (the "Company") hereby certifies that to the best of my knowledge the Company's Quarterly Report on Form 10-Q for the quarter ended April 30, 2026 (the "Report") fully complies with the requirements of Section 13(a) or 15(d), as applicable, of the Securities Exchange Act of 1934 and that the information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company.

---

| | |
|:---|:---|
| Dated: | June 8, 2026 |
| /s/ Susan M. Kreh | /s/ Susan M. Kreh |
| Name: Susan M. Kreh<br>Title: Chief Financial Officer | Name: Susan M. Kreh<br>Title: Chief Financial Officer |

---

A signed original of this written statement required by Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

The foregoing certification is being furnished solely pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (Section 1350, Chapter 63 of Title 18, United States Code) and is not being filed as part of the Report or as a separate disclosure document.

## Ex-95

**Exhibit 95**

**MINE SAFETY DISCLOSURES**

Under section 1503(a) of the Dodd-Frank Wall Street Reform and Consumer Protection Act and Item 104 of Regulation S-K, each operator of a coal or other mine is required to include certain mine safety information in its periodic reports filed with the Securities and Exchange Commission. The table below includes this mine safety information for each mine facility owned and operated by Oil-Dri Corporation of America, or its subsidiaries, for the quarter ended April 30, 2026. Due to timing and other factors, our data may not agree with the mine data retrieval system maintained by the Mine Safety and Health Administration ("MSHA"). The columns in the table represent the total number of, and the proposed dollar assessment for, violations, citations and orders issued by MSHA during the period upon periodic inspection of our mine facilities in accordance with the referenced sections of the Federal Mine Safety and Health Act of 1977, as amended (the "Mine Act"), described as follows:

Section 104 Significant and Substantial Violations: Total number of violations of mandatory health or safety standards that could significantly and substantially contribute to the cause and effect of a coal or other mine safety or health hazard.

Section 104(b) Orders: Total number of orders issued due to a failure to totally abate, within the time period prescribed by MSHA, a violation previously cited under section 104, which results in the issuance of an order requiring the mine operator to immediately withdraw all persons from the mine.

Section 104(d) Citations and Orders: Total number of citations and orders issued for unwarrantable failure of the mine operator to comply with mandatory health and safety standards. The violation could significantly and substantially contribute to the cause and effect of a safety and health hazard, but the conditions do not cause imminent danger.

Section 110(b)(2) Flagrant Violations: Total number of flagrant violations defined as a reckless or repeated failure to make reasonable efforts to eliminate a known violation of a mandatory health or safety standard that substantially and proximately caused, or reasonably could have been expected to cause, death or serious bodily injury.

Section 107(a) Imminent Danger Orders: Total number of orders issued when an imminent danger is identified which requires all persons to be withdrawn from area(s) in the mine until the imminent danger and the conditions that caused it cease to exist.

Total Dollar Value of Proposed MSHA Assessments: Each issuance of a citation or order by MSHA results in the assessment of a monetary penalty. The total dollar value presented includes any contested penalties.

Legal Actions Pending, Initiated or Resolved: Total number of cases pending legal action before the Federal Mine Safety and Health Review Commission (the "Commission") as of the last day of the reporting period or the number of such cases initiated or resolved during the reporting period.

---

| | | | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | | | | | | | | | Legal Actions | Legal Actions | Legal Actions |
| Mine ID | Mine Location | Section 104 "Significant and Substantial" Violations | Section 104(b)<br>Orders | Section 104(d)<br>Citations and Orders | Section 110(b)(2) Flagrant Violations | Section 107(a) Imminent Danger Orders | Total Dollar Value of Proposed MSHA Assessments | Mining Related Fatalities | Pending as of Last Day of Period | Initiated During Period | Resolved During Period |
|  |  | (#) | (#) | (#) | (#) | (#) | ($) | (#) | (#) | (#) | (#) |
| 0900114 | Ochlocknee, Georgia |  |  |  |  |  |  |  |  |  |  |
| 2200035 | Ripley, Mississippi | 1 |  |  |  |  | 3743 |  |  |  |  |
| 1102403 | Mounds, Illinois |  |  |  |  |  |  |  |  |  |  |
| 2200582 | Blue Mountain, Mississippi |  |  |  |  |  | 650 |  |  |  |  |
| 0402964 | Taft, California |  |  |  |  |  | 769 |  |  |  |  |

---

------

During this period we received no written notices from MSHA under section 104(e) of the Mine Act of (i) a pattern of violations of mandatory health or safety standards that are of such nature as could have significantly and substantially contributed to the cause and effect of coal or other mine health or safety hazards; or (ii) the potential to have such a pattern.

Legal actions pending before the Commission may involve, among other questions, challenges by operators to citations, orders and penalties they have received from MSHA or complaints of discrimination by miners under section 105 of the Mine Act. The following is a brief description of the types of legal actions that may be brought before the Commission.

Contests of Citations and Orders: A contest proceeding may be filed with the Commission by operators, miners or miners' representatives to challenge the issuance of a citation or order issued by MSHA.

Contests of Proposed Penalties (Petitions for Assessment of Penalties): A contest of a proposed penalty is an administrative proceeding before the Commission challenging a civil penalty that MSHA has proposed for the alleged violation contained in a citation or order. The validity of the citation may also be challenged in this proceeding as well.

Complaints for Compensation: A complaint for compensation may be filed with the Commission by miners entitled to compensation when a mine is closed by certain withdrawal orders issued by MSHA. The purpose of the proceeding is to determine the amount of compensation, if any, due miners idled by the orders.

Complaints of Discharge, Discrimination or Interference: A discrimination proceeding is a case that involves a miner's allegation that he or she has suffered a wrong by the operator because he or she engaged in some type of activity protected under the Mine Act, such as making a safety complaint.

Applications for Temporary Relief: An application for temporary relief from any modification or termination of any order or from any order issued under section 104 of the Mine Act.

Appeals of Judges' Decisions or Orders to the Commission: A filing with the Commission of a petition for discretionary review of a Judge's decision or order by a person who has been adversely affected or aggrieved by such decision or order.

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| Mine ID | Mine location | Contests of Citations and Orders | Contests of Proposed Penalties | Complaints for Compensation | Complaints of Discharge, Discrimination or Interference | Applications for Temporary Relief | Appeals of Judges Decisions or Orders to the Commission |
| 0900114 | Ochlocknee, Georgia |  |  |  |  |  |  |
| 2200035 | Ripley, Mississippi |  |  |  |  |  |  |
| 1102403 | Mounds, Illinois |  |  |  |  |  |  |
| 2200582 | Blue Mountain, Mississippi |  |  |  |  |  |  |
| 0402964 | Taft, California |  |  |  |  |  |  |

---